A broad-spectrum antimicrobial carboxyfluoroquinoline.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Substances that reduce the growth or reproduction of BACTERIA.
A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.
A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Gyrase binds to DNA as a heterotetramer consisting of two A and two B subunits. In the presence of ATP, gyrase is able to convert the relaxed circular DNA duplex into a superhelix. In the absence of ATP, supercoiled DNA is relaxed by DNA gyrase.
The L-isomer of Ofloxacin.
Quinolines are heterocyclic aromatic organic compounds consisting of a two-nitrogened benzene ring fused to a pyridine ring, which have been synthesized and used as building blocks for various medicinal drugs, particularly antibiotics and antimalarials.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Topoisomerase IV binds to DNA as a heterotetramer consisting 2 parC and 2 parE subunits. Topoisomerase IV is a decatenating enzyme that resolves interlinked daughter chromosomes following DNA replication.
A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.
'Azā compounds' are a class of organic molecules containing at least one nitrogen atom in a five-membered ring, often found in naturally occurring substances and pharmaceuticals, with the name derived from the Arabic word "azZa" meaning 'strong' referring to the ring's aromatic stability.
A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria.
QUINOLONES containing a 4-oxo (a carbonyl in the para position to the nitrogen). They inhibit the A subunit of DNA GYRASE and are used as antimicrobials. Second generation 4-quinolones are also substituted with a 1-piperazinyl group at the 7-position and a fluorine at the 6-position.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
Infections with bacteria of the genus PSEUDOMONAS.
Bacteria which retain the crystal violet stain when treated by Gram's method.
Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.
A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
A serotype of SALMONELLA ENTERICA that causes mild PARATYPHOID FEVER in humans.
The giving of drugs, chemicals, or other substances by mouth.
Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.
A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA.
A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER.
An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.
Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
Aerobic bacteria are types of microbes that require oxygen to grow and reproduce, and use it in the process of respiration to break down organic matter and produce energy, often found in environments where oxygen is readily available such as the human body's skin, mouth, and intestines.
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Infections by bacteria, general or unspecified.
'Anaerobic Bacteria' are types of bacteria that do not require oxygen for growth and can often cause diseases in humans, including dental caries, gas gangrene, and tetanus, among others.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Therapy with two or more separate preparations given for a combined effect.
A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)
This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
A prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe.
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Infections in the inner or external eye caused by microorganisms belonging to several families of bacteria. Some of the more common genera found are Haemophilus, Neisseria, Staphylococcus, Streptococcus, and Chlamydia.
The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
Infections with bacteria of the genus STAPHYLOCOCCUS.
The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity.
Method of measuring the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy. It is used to monitor the therapy in BACTERIAL ENDOCARDITIS; OSTEOMYELITIS and other serious bacterial infections. As commonly performed, the test is a variation of the broth dilution test. This test needs to be distinguished from testing of the naturally occurring BLOOD BACTERICIDAL ACTIVITY.
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.
Infections with bacteria of the species ESCHERICHIA COLI.
A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992)
Infections with bacteria of the genus SALMONELLA.
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
Semisynthetic broad-spectrum cephalosporin.
A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.
A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.
Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
A semisynthetic ampicillin-derived acylureido penicillin.
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.
Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors.
The action of a drug that may affect the activity, metabolism, or toxicity of another drug.
Nonsusceptibility of an organism to the action of penicillins.
One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
Deoxyribonucleic acid that makes up the genetic material of bacteria.
A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
A device that delivers medication to the lungs in the form of a dry powder.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
Inflammation of the cornea.
A synthetic tetracycline derivative with similar antimicrobial activity.
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.
Any infection which a patient contracts in a health-care institution.
An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.
A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.
Injections made into a vein for therapeutic or experimental purposes.
Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative.
A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.
A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals.
A rapid-growing, nonphotochromogenic species that is potentially pathogenic, producing lesions of lung, bone, or soft tissue following trauma. It has been found in soil and in injection sites of humans, cattle, and cold-blooded animals. (Dorland, 28th ed)
A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985, p133), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed).

Ciprofloxacin decreases the rate of ethanol elimination in humans. (1/2353)

BACKGROUND: Extrahepatic ethanol metabolism is postulated to take place via microbial oxidation in the colon, mediated by aerobic and facultative anaerobic bacteria. AIMS: To evaluate the role of microbial ethanol oxidation in the total elimination rate of ethanol in humans by reducing gut flora with ciprofloxacin. METHODS: Ethanol was administered intravenously at the beginning and end of a one week period to eight male volunteers. Between ethanol doses volunteers received 750 mg ciprofloxacin twice daily. RESULTS: A highly significant (p=0.001) reduction in the ethanol elimination rate (EER) was detected after ciprofloxacin medication. Mean (SEM) EER was 107.0 (5.3) and 96.9 (4.8) mg/kg/h before and after ciprofloxacin, respectively. Faecal Enterobacteriaceae and Enterococcus sp. were totally absent after medication, and faecal acetaldehyde production capacity was significantly (p<0.05) decreased from 0.91 (0.15) to 0.39 (0.08) nmol/min/mg protein. Mean faecal alcohol dehydrogenase (ADH) activity was significantly (p<0. 05) decreased after medication, but ciprofloxacin did not inhibit human hepatic ADH activity in vitro. CONCLUSIONS: Ciprofloxacin treatment decreased the ethanol elimination rate by 9.4%, with a concomitant decrease in intestinal aerobic and facultative anaerobic bacteria, faecal ADH activity, and acetaldehyde production. As ciprofloxacin has no effect on liver blood flow, hepatic ADH activity, or cytochrome CYP2E1 activity, these effects are probably caused by the reduction in intestinal flora.  (+info)

Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. (2/2353)

During a randomized study of clarithromycin plus clofazimine with or without ethambutol in patients with AIDS and Mycobacterium avium complex (MAC) bacteremia, eight participants received additional antimycobacterial drugs following the detection of a clarithromycin-resistant isolate (MIC, > 8 micrograms/mL). A macrolide (seven received clarithromycin, one azithromycin) and clofazimine were continued; additional treatment included various combinations of ethambutol, ciprofloxacin, amikacin, and rifabutin. After the detection of a resistant isolate and before receipt of additional antimycobacterials, the median peak MAC colony count in blood was 105 cfu/mL (range, 8-81,500 cfu/mL). After additional antimycobacterials, the median nadir MAC colony count was 5 cfu/mL (range, 0-110 cfu/mL). Five (63%) of eight patients had a > or = 1 log10 decrease, including two who achieved negative blood cultures; all of these responses occurred in patients originally assigned to clarithromycin plus clofazimine. Treatment of clarithromycin-resistant MAC bacteremia that emerges during clarithromycin-based treatment can decrease levels of bacteremia and transiently sterilize blood cultures.  (+info)

Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. (3/2353)

The effect of an extensive prophylactic antimicrobial regimen was prospectively assessed in 126 patients after high-dose chemotherapy and autologous PBSC. They received ciprofloxacin (500 mg/12 h), acyclovir (200 mg/6 h), and itraconazole (200 mg/12 h) orally until neutrophil recovery. Febrile patients received i.v. imipenem (500 mg/6 h) to which vancomycin and amikacin were added if fever persisted for 2-3 and 5 days, respectively. Amphotericin B lipid complex was further given on day 7 or 8 of fever. Median times for a neutrophil count of >0.5 x 10(9)/l and a platelet count of >20 x 10(9)/l were 9 and 11 days. Severe neutropenia (<0.1 x 10(9)/l) lasted for a median of 5 days in which 72% of febrile episodes and 50% of cases of bacteremia occurred. Gram-positive bacteria were isolated in 30 of 40 episodes of bacteremia, 25 of which were caused by Staphylococcus epidermidis. Clinical foci were the intravascular catheter in 35 cases, respiratory infection in 11, cellulitis in two, anal abscess in one, and neutropenic enterocolitis in one. The high incidence of febrile episodes (94%) and bacteremias (31%) may be due to the lack of efficacy of antimicrobial prophylaxis and the persistence of a 5-day period of severe neutropenia.  (+info)

Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model. (4/2353)

The effect of inoculum size (N0) on antimicrobial action has not been extensively studied in in vitro dynamic models. To investigate this effect and its predictability, killing and regrowth kinetics of Staphylococcus aureus and Escherichia coli exposed to monoexponentially decreasing concentrations of trovafloxacin (as a single dose) and ciprofloxacin (two doses at a 12-h interval) were compared at N0 = 10(6) and 10(9) CFU/ml (S. aureus) and at N0 = 10(6), 10(7), and 10(9) CFU/ml (E. coli). A series of pharmacokinetic profiles of trovafloxacin and ciprofloxacin with respective half-lives of 9.2 and 4 h were simulated at different ratios of area under the concentration-time curve (AUC) to MIC (in [micrograms x hours/milliliter]/[micrograms/milliliter]): 58 to 466 with trovafloxacin and 116 to 932 with ciprofloxacin for S. aureus and 58 to 233 and 116 to 466 for E. coli, respectively. Although the effect of N0 was more pronounced for E. coli than for S. aureus, only a minor increase in minimum numbers of surviving bacteria and an almost negligible delay in their regrowth were associated with an increase of the N0 for both organisms. The N0-induced reductions of the intensity of the antimicrobial effect (IE, area between control growth and the killing-regrowth curves) were also relatively small. However, the N0 effect could not be eliminated either by simple shifting of the time-kill curves obtained at higher N0s by the difference between the higher and lowest N0 or by operating with IEs determined within the N0-adopted upper limits of bacterial numbers (IE's). By using multivariate correlation and regression analyses, linear relationships between IE and log AUC/MIC and log N0 related to the respective mean values [(log AUC/MIC)average and (log N0)average] were established for both trovafloxacin and ciprofloxacin against each of the strains (r2 = 0.97 to 0.99). The antimicrobial effect may be accurately predicted at a given AUC/MIC of trovafloxacin or ciprofloxacin and at a given N0 based on the relationship IE = a + b [(log AUC/MIC)/(log AUC/MIC)average] - c [(log N0)/(log N0)average]. Moreover, the relative impacts of AUC/MIC and N0 on IE may be evaluated. Since the c/b ratios for trovafloxacin and ciprofloxacin against E. coli were much lower (0.3 to 0.4) than that for ampicillin-sulbactam as examined previously (1.9), the inoculum effect with the quinolones may be much less pronounced than with the beta-lactams. The described approach to the analysis of the inoculum effect in in vitro dynamic models might be useful in studies with other antibiotic classes.  (+info)

Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. (5/2353)

The impact of acidification and alkalinization of urine on the pharmacokinetics of ciprofloxacin was investigated after single 200-mg oral doses were administered to nine healthy male volunteers. In addition, the effect of human urine on the MICs of ciprofloxacin and sparfloxacin against some common urinary tract pathogens such as Escherichia coli and Pseudomonas aeruginosa was investigated. Acidic and alkaline conditions were achieved by repeated oral doses of ammonium chloride or sodium bicarbonate, respectively. Plasma ciprofloxacin levels in all subjects were adequately described in terms of two-compartment model kinetics with first-order absorption. Acidification and alkalinization treatments had no effect on ciprofloxacin absorption, distribution, or elimination. The total amount of unchanged ciprofloxacin excreted over 24 h under acidic conditions was 88.4 +/- 14.5 mg (mean +/- standard deviation) (44.2% of the oral dose) and 82.4 +/- 16.5 mg (41.2% of the oral dose) under alkaline conditions, while the total amount of unchanged drug excreted over 24 h in volunteers receiving neither sodium bicarbonate nor ammonium chloride was 90.53 +/- 9.8 mg (45.2% of the oral dose). The mean renal clearance of ciprofloxacin was 16.78 +/- 2.67, 16.08 +/- 3.2, and 16.31 +/- 2.67 liters/h with acidification, alkalinization, and control, respectively. Renal clearance and concentrations of ciprofloxacin in urine were not correlated with urinary pH. The antibacterial activity of ciprofloxacin and sparfloxacin against E. coli NIHJ JC-2 and P. aeruginosa ATCC 27853 was affected by human urine and in particular by its pH. The activities of both quinolones against E. coli NIHJ JC-2 were lower at lower urinary pH and rather uniform, while in the case of P. aeruginosa ATCC 27853 ciprofloxacin was more active than sparfloxacin.  (+info)

Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages. (6/2353)

When the lethal action of a C-8 methoxyl fluoroquinolone against clinical isolates of Mycobacterium tuberculosis in liquid medium was measured, the compound was found to be three to four times more effective (as determined by measuring the 90% lethal dose) than a C-8-H control fluoroquinolone or ciprofloxacin against cells having a wild-type gyrA (gyrase) gene. Against ciprofloxacin-resistant strains, the C-8 methoxyl group enhanced lethality when alanine was replaced by valine at position 90 of the GyrA protein or when aspartic acid 94 was replaced by glycine, histidine, or tyrosine. During infection of a human macrophage model by wild-type Mycobacterium bovis BCG, the C-8 methoxyl group lowered survival 20- to 100-fold compared with the same concentration of a C-8-H fluoroquinolone. The C-8 methoxyl fluoroquinolone was also more effective than ciprofloxacin against a gyrA Asn94 mutant of M. bovis BCG. In an M. tuberculosis-macrophage system the C-8 methoxyl group improved fluoroquinolone action against both quinolone-susceptible and quinolone-resistant clinical isolates. Thus, a C-8 methoxyl group enhances the bactericidal activity of quinolones with N1-cyclopropyl substitutions; these data encourage further refinement of fluoroquinolones as antituberculosis agents.  (+info)

Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess. (7/2353)

Oral levofloxacin was compared to oral ciprofloxacin in a Staphylococcus aureus subcutaneous abscess model in rabbits. Rabbits were surgically prepared with subcutaneous wiffle balls (43 mm in diameter) and allowed to recover for 4 to 6 weeks. Rabbits were infected by direct injection into the capsule with S. aureus ATCC 29213 (5 x 10(5) CFU) and were allowed to remain infected for 8 days before the initiation of anti-infective treatment. Efficacy was determined by assessing the bacterial load within the capsule over a 10-day treatment period. In single-dose pharmacokinetic studies in infected rabbits, similar area under the concentration-time curve/MIC ratios were obtained in the plasma and abscess fluid for levofloxacin at 45 mg/kg of body weight and ciprofloxacin at 200 mg/kg of body weight. Similar efficacies were seen with levofloxacin at 45 mg/kg/day and ciprofloxacin 400 mg/kg/day by day 10. In this model, levofloxacin was significantly more efficacious than ciprofloxacin (P < 0.01).  (+info)

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. (8/2353)

The increasing frequency of penicillin-resistant pneumococcus continues to be of concern throughout the world. Newer fluoroquinolone antibiotics, such as levofloxacin, have shown enhanced in vitro activity against Streptococcus pneumoniae. In this study, the bactericidal characteristics and pharmacodynamic profiles of levofloxacin, ciprofloxacin, and ampicillin against four isolates of S. pneumoniae were compared by using an in vitro model of infection. Standard antibiotic dosing regimens which simulated the pharmacokinetic profile observed in humans were used. Control and treatment models were sampled for bacterial CFU per milliliter over the duration of each 24- or 48-h experiment. In addition, treatment models were sampled for MIC determinations and drug concentration. Regrowth of all isolates as well as an increase in MICs throughout the study period was observed in the ciprofloxacin experiments. A limited amount of regrowth was noted during levofloxacin therapy for one isolate; however, no change in MIC was detected for any isolate. Ampicillin showed rapid and sustained bactericidal activity against all isolates. In this study, ratios of effective fluoroquinolone area under the concentration-time curve (AUC):MIC values ranged from 30 to 55. Levofloxacin, owing to its larger AUC0-24 values, has excellent and sustained activity against different pneumococcal strains superior to that of ciprofloxacin.  (+info)

Ciprofloxacin is a fluoroquinolone antibiotic that is used to treat various types of bacterial infections, including respiratory, urinary, and skin infections. It works by inhibiting the bacterial DNA gyrase, which is an enzyme necessary for bacterial replication and transcription. This leads to bacterial cell death. Ciprofloxacin is available in oral and injectable forms and is usually prescribed to be taken twice a day. Common side effects include nausea, diarrhea, and headache. It may also cause serious adverse reactions such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is important to note that ciprofloxacin should not be used in patients with a history of hypersensitivity to fluoroquinolones and should be used with caution in patients with a history of seizures, brain injury, or other neurological conditions.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

Fluoroquinolones are a class of antibiotics that are widely used to treat various types of bacterial infections. They work by interfering with the bacteria's ability to replicate its DNA, which ultimately leads to the death of the bacterial cells. Fluoroquinolones are known for their broad-spectrum activity against both gram-positive and gram-negative bacteria.

Some common fluoroquinolones include ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin. These antibiotics are often used to treat respiratory infections, urinary tract infections, skin infections, and gastrointestinal infections, among others.

While fluoroquinolones are generally well-tolerated, they can cause serious side effects in some people, including tendonitis, nerve damage, and changes in mood or behavior. As with all antibiotics, it's important to use fluoroquinolones only when necessary and under the guidance of a healthcare provider.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Quinolones are a class of antibacterial agents that are widely used in medicine to treat various types of infections caused by susceptible bacteria. These synthetic drugs contain a chemical structure related to quinoline and have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Quinolones work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, and repair.

The first quinolone antibiotic was nalidixic acid, discovered in 1962. Since then, several generations of quinolones have been developed, with each generation having improved antibacterial activity and a broader spectrum of action compared to the previous one. The various generations of quinolones include:

1. First-generation quinolones (e.g., nalidixic acid): Primarily used for treating urinary tract infections caused by Gram-negative bacteria.
2. Second-generation quinolones (e.g., ciprofloxacin, ofloxacin, norfloxacin): These drugs have improved activity against both Gram-positive and Gram-negative bacteria and are used to treat a wider range of infections, including respiratory, gastrointestinal, and skin infections.
3. Third-generation quinolones (e.g., levofloxacin, sparfloxacin, grepafloxacin): These drugs have enhanced activity against Gram-positive bacteria, including some anaerobes and atypical organisms like Legionella and Mycoplasma species.
4. Fourth-generation quinolones (e.g., moxifloxacin, gatifloxacin): These drugs have the broadest spectrum of activity, including enhanced activity against Gram-positive bacteria, anaerobes, and some methicillin-resistant Staphylococcus aureus (MRSA) strains.

Quinolones are generally well-tolerated, but like all medications, they can have side effects. Common adverse reactions include gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, and dizziness. Serious side effects, such as tendinitis, tendon rupture, peripheral neuropathy, and QT interval prolongation, are less common but can occur, particularly in older patients or those with underlying medical conditions. The use of quinolones should be avoided or used cautiously in these populations.

Quinolone resistance has become an increasing concern due to the widespread use of these antibiotics. Bacteria can develop resistance through various mechanisms, including chromosomal mutations and the acquisition of plasmid-mediated quinolone resistance genes. The overuse and misuse of quinolones contribute to the emergence and spread of resistant strains, which can limit treatment options for severe infections caused by these bacteria. Therefore, it is essential to use quinolones judiciously and only when clinically indicated, to help preserve their effectiveness and prevent further resistance development.

Ofloxacin is an antibacterial drug, specifically a fluoroquinolone. It works by inhibiting the bacterial DNA gyrase, which is essential for the bacteria to replicate. This results in the death of the bacteria and helps to stop the infection. Ofloxacin is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and sexually transmitted diseases. It is available in various forms, such as tablets, capsules, and eye drops. As with any medication, it should be used only under the direction of a healthcare professional, and its use may be associated with certain risks and side effects.

Bacterial drug resistance is a type of antimicrobial resistance that occurs when bacteria evolve the ability to survive and reproduce in the presence of drugs (such as antibiotics) that would normally kill them or inhibit their growth. This can happen due to various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

As a result, bacterial infections may become more difficult to treat, requiring higher doses of medication, alternative drugs, or longer treatment courses. In some cases, drug-resistant infections can lead to serious health complications, increased healthcare costs, and higher mortality rates.

Examples of bacterial drug resistance include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug-resistant tuberculosis (MDR-TB). Preventing the spread of bacterial drug resistance is crucial for maintaining effective treatments for infectious diseases.

DNA gyrase is a type II topoisomerase enzyme that plays a crucial role in the negative supercoiling and relaxation of DNA in bacteria. It functions by introducing transient double-stranded breaks into the DNA helix, allowing the strands to pass through one another and thereby reducing positive supercoils or introducing negative supercoils as required for proper DNA function, replication, and transcription.

DNA gyrase is composed of two subunits, GyrA and GyrB, which form a heterotetrameric structure (AB-BA) in the functional enzyme. The enzyme's activity is targeted by several antibiotics, such as fluoroquinolones and novobiocin, making it an essential target for antibacterial drug development.

In summary, DNA gyrase is a bacterial topoisomerase responsible for maintaining the correct supercoiling of DNA during replication and transcription, which can be inhibited by specific antibiotics to combat bacterial infections.

Levofloxacin is an antibiotic medication that belongs to the fluoroquinolone class. It works by interfering with the bacterial DNA replication, transcription, and repair processes, leading to bacterial cell death. Levofloxacin is used to treat a variety of infections caused by susceptible bacteria, including respiratory, skin, urinary tract, and gastrointestinal infections. It is available in various forms, such as tablets, oral solution, and injection, for different routes of administration.

The medical definition of Levofloxacin can be stated as:

Levofloxacin is a synthetic antibacterial drug with the chemical name (-)-(S)-9-fluoro-2,3-dihydro-3-methoxy-10-(4-methyl-1-piperazinyl)-9-oxoanthracene-1-carboxylic acid l-alanyl-l-proline methylester monohydrate. It is the levo isomer of ofloxacin and is used to treat a wide range of bacterial infections by inhibiting bacterial DNA gyrase, thereby preventing DNA replication and transcription. Levofloxacin is available as tablets, oral solution, and injection for oral and parenteral administration.

Quinolines are a class of organic compounds that consist of a bicyclic structure made up of a benzene ring fused to a piperidine ring. They have a wide range of applications, but they are perhaps best known for their use in the synthesis of various medications, including antibiotics and antimalarial drugs.

Quinolone antibiotics, such as ciprofloxacin and levofloxacin, work by inhibiting the bacterial enzymes involved in DNA replication and repair. They are commonly used to treat a variety of bacterial infections, including urinary tract infections, pneumonia, and skin infections.

Quinoline-based antimalarial drugs, such as chloroquine and hydroxychloroquine, work by inhibiting the parasite's ability to digest hemoglobin in the red blood cells. They are commonly used to prevent and treat malaria.

It is important to note that quinolines have been associated with serious side effects, including tendinitis and tendon rupture, nerve damage, and abnormal heart rhythms. As with any medication, it is important to use quinolines only under the supervision of a healthcare provider, and to follow their instructions carefully.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

Norfloxacin is a fluoroquinolone antibiotic that is primarily used to treat bacterial infections of the urinary tract, prostate, and skin. It works by inhibiting the bacterial DNA gyrase, which is an essential enzyme involved in DNA replication. This leads to bacterial cell death. Norfloxacin is available as a generic medication and is usually prescribed in oral form, such as tablets or suspension.

Here's the medical definition of Norfloxacin:

Norfloxacin (norfloxacinum) - A synthetic fluoroquinolone antibiotic with a broad spectrum of activity against gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa. It is used to treat urinary tract infections, prostatitis, and skin infections. Norfloxacin inhibits bacterial DNA gyrase, which results in bacterial cell death. The drug is available as a generic medication and is usually prescribed in oral form, such as tablets or suspension. Common side effects include nausea, diarrhea, headache, and dizziness. Norfloxacin may also cause serious adverse reactions, including tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is contraindicated in patients with a history of hypersensitivity to quinolones or fluoroquinolones.

DNA Topoisomerase IV is a type of enzyme that plays a crucial role in the relaxation and manipulation of supercoiled DNA during processes such as replication, transcription, and chromosome segregation. It functions by temporarily cleaving and rejoining the DNA strands to allow for the unlinking and separation of DNA molecules. This enzyme primarily targets double-stranded DNA and is especially important in bacteria, where it helps to resolve the topological challenges that arise during DNA replication and segregation of daughter chromosomes during cell division. Inhibition of DNA Topoisomerase IV has been explored as a strategy for developing antibacterial drugs, as this enzyme is essential for bacterial survival and is not found in humans.

Nalidixic acid is an antimicrobial agent, specifically a synthetic quinolone derivative. It is primarily used for the treatment of urinary tract infections caused by susceptible strains of gram-negative bacteria, such as Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.

Nalidixic acid works by inhibiting bacterial DNA gyrase, an enzyme necessary for DNA replication. This leads to the prevention of DNA synthesis and ultimately results in bacterial cell death. However, its use has become limited due to the emergence of resistance and the availability of more effective antimicrobials.

It is essential to note that nalidixic acid is not typically used as a first-line treatment for urinary tract infections or any other type of infection. It should only be used when other antibiotics are not suitable due to resistance, allergies, or other factors. Additionally, the drug's potential side effects, such as gastrointestinal disturbances, headaches, and dizziness, may limit its use in some patients.

'Aza compounds' is a general term used in chemistry to describe organic compounds containing a nitrogen atom (denoted by the symbol 'N' or 'aza') that has replaced a carbon atom in a hydrocarbon structure. The term 'aza' comes from the Greek word for nitrogen, 'azote.'

In medicinal chemistry and pharmacology, aza compounds are of particular interest because the presence of the nitrogen atom can significantly affect the chemical and biological properties of the compound. For example, aza compounds may exhibit enhanced bioavailability, metabolic stability, or receptor binding affinity compared to their non-aza counterparts.

Some common examples of aza compounds in medicine include:

1. Aza-aromatic compounds: These are aromatic compounds that contain one or more nitrogen atoms in the ring structure. Examples include pyridine, quinoline, and isoquinoline derivatives, which have been used as anti-malarial, anti-inflammatory, and anti-cancer agents.
2. Aza-heterocyclic compounds: These are non-aromatic compounds that contain one or more nitrogen atoms in a cyclic structure. Examples include azepine, diazepine, and triazole derivatives, which have been used as anxiolytic, anti-viral, and anti-fungal agents.
3. Aza-peptides: These are peptide compounds that contain one or more nitrogen atoms in the backbone structure. Examples include azapeptides and azabicyclopeptides, which have been used as enzyme inhibitors and neuroprotective agents.
4. Aza-sugars: These are sugar derivatives that contain one or more nitrogen atoms in the ring structure. Examples include azasugars and iminosugars, which have been used as glycosidase inhibitors and anti-viral agents.

Overall, aza compounds represent an important class of medicinal agents with diverse chemical structures and biological activities.

Pefloxacin is a fluoroquinolone antibiotic that is primarily used to treat various types of bacterial infections, such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted diseases. It works by inhibiting the DNA gyrase enzyme in bacteria, which is necessary for their replication and survival.

The medical definition of Pefloxacin can be stated as follows:

Pefloxacin (INN, USAN) - a fluoroquinolone antibiotic with bactericidal activity against a wide range of gram-positive and gram-negative bacteria. It is used to treat various types of infections caused by susceptible organisms, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted diseases. Pefloxacin is available as an oral tablet or injection for intravenous use.

It's important to note that the use of fluoroquinolones like pefloxacin should be reserved for treating serious bacterial infections that are unresponsive to other antibiotics, due to concerns about their potential side effects and the risk of developing antibiotic resistance.

4-Quinolones are a class of antibacterial agents that are chemically characterized by a 4-oxo-1,4-dihydroquinoline ring. They include drugs such as ciprofloxacin, levofloxacin, and moxifloxacin, among others. These antibiotics work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, repair, and recombination. This leads to bacterial cell death.

4-Quinolones have a broad spectrum of activity against both Gram-positive and Gram-negative bacteria and are used to treat a variety of infections, including urinary tract infections, pneumonia, skin and soft tissue infections, and intra-abdominal infections. However, the use of 4-quinolones is associated with an increased risk of tendinitis and tendon rupture, as well as other serious adverse effects such as peripheral neuropathy, QT interval prolongation, and aortic aneurysm and dissection. Therefore, their use should be restricted to situations where the benefits outweigh the risks.

Multiple bacterial drug resistance (MDR) is a medical term that refers to the resistance of multiple strains of bacteria to several antibiotics or antimicrobial agents. This means that these bacteria have developed mechanisms that enable them to survive and multiply despite being exposed to drugs that were previously effective in treating infections caused by them.

MDR is a significant public health concern because it limits the treatment options available for bacterial infections, making them more difficult and expensive to treat. In some cases, MDR bacteria may cause severe or life-threatening infections that are resistant to all available antibiotics, leaving doctors with few or no effective therapeutic options.

MDR can arise due to various mechanisms, including the production of enzymes that inactivate antibiotics, changes in bacterial cell membrane permeability that prevent antibiotics from entering the bacteria, and the development of efflux pumps that expel antibiotics out of the bacteria. The misuse or overuse of antibiotics is a significant contributor to the emergence and spread of MDR bacteria.

Preventing and controlling the spread of MDR bacteria requires a multifaceted approach, including the judicious use of antibiotics, infection control measures, surveillance, and research into new antimicrobial agents.

"Pseudomonas aeruginosa" is a medically important, gram-negative, rod-shaped bacterium that is widely found in the environment, such as in soil, water, and on plants. It's an opportunistic pathogen, meaning it usually doesn't cause infection in healthy individuals but can cause severe and sometimes life-threatening infections in people with weakened immune systems, burns, or chronic lung diseases like cystic fibrosis.

P. aeruginosa is known for its remarkable ability to resist many antibiotics and disinfectants due to its intrinsic resistance mechanisms and the acquisition of additional resistance determinants. It can cause various types of infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, dermatitis, and severe bloodstream infections known as sepsis.

The bacterium produces a variety of virulence factors that contribute to its pathogenicity, such as exotoxins, proteases, and pigments like pyocyanin and pyoverdine, which aid in iron acquisition and help the organism evade host immune responses. Effective infection control measures, appropriate use of antibiotics, and close monitoring of high-risk patients are crucial for managing P. aeruginosa infections.

Enoxacin is an antibiotic that belongs to a class of drugs called fluoroquinolones. It works by inhibiting the bacterial DNA gyrase, which is an essential enzyme involved in DNA replication and transcription. This leads to bacterial cell death and helps to treat various infections caused by susceptible bacteria. Enoxacin is used to treat a wide range of bacterial infections, including respiratory, urinary tract, skin, and soft tissue infections.

The medical definition of Enoxacin can be stated as:

Enoxacin (INN, USAN, JAN) is a fluoroquinolone antibiotic used to treat various bacterial infections. It is an inhibitor of DNA gyrase and has been found to have good activity against both Gram-positive and Gram-negative bacteria. Enoxacin is available as a 200 mg tablet for oral administration, and its typical dosage ranges from 200 to 600 mg per day, depending on the type and severity of the infection being treated.

It's important to note that like other fluoroquinolones, Enoxacin carries a risk of serious side effects, including tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, and exacerbation of myasthenia gravis. Therefore, it should be used with caution and only when other antibiotics are not appropriate or have failed.

Fleroxacin is a fluoroquinolone antibiotic that is used to treat various types of bacterial infections, including respiratory, urinary tract, and skin infections. It works by inhibiting the DNA gyrase enzyme in bacteria, which is necessary for their replication and survival.

Fleroxacin has a broad spectrum of activity against both gram-positive and gram-negative bacteria, making it useful for treating a variety of infections caused by these organisms. However, like other fluoroquinolones, fleroxacin carries a risk of serious side effects, including tendinitis, tendon rupture, nerve damage, and other central nervous system effects. Therefore, its use is generally reserved for situations where other antibiotics are not effective or appropriate.

Fleroxacin is available in oral tablet form and is typically taken twice daily with a full glass of water. It should be taken on an empty stomach, at least one hour before or two hours after meals. The dosage and duration of treatment will depend on the type and severity of the infection being treated, as well as the patient's overall health status.

It is important to note that fleroxacin, like all antibiotics, should only be used under the guidance of a healthcare professional, and should not be used for viral infections such as the common cold or flu. Misuse of antibiotics can lead to antibiotic resistance, which makes it more difficult to treat bacterial infections in the future.

Gram-negative bacteria are a type of bacteria that do not retain the crystal violet stain used in the Gram staining method, a standard technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This method was developed by Hans Christian Gram in 1884.

The primary characteristic distinguishing Gram-negative bacteria from Gram-positive bacteria is the composition and structure of their cell walls:

1. Cell wall: Gram-negative bacteria have a thin peptidoglycan layer, making it more susceptible to damage and less rigid compared to Gram-positive bacteria.
2. Outer membrane: They possess an additional outer membrane that contains lipopolysaccharides (LPS), which are endotoxins that can trigger strong immune responses in humans and animals. The outer membrane also contains proteins, known as porins, which form channels for the passage of molecules into and out of the cell.
3. Periplasm: Between the inner and outer membranes lies a compartment called the periplasm, where various enzymes and other molecules are located.

Some examples of Gram-negative bacteria include Escherichia coli (E. coli), Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella enterica, Shigella spp., and Neisseria meningitidis. These bacteria are often associated with various infections, such as urinary tract infections, pneumonia, sepsis, and meningitis. Due to their complex cell wall structure, Gram-negative bacteria can be more resistant to certain antibiotics, making them a significant concern in healthcare settings.

Staphylococcus aureus is a type of gram-positive, round (coccal) bacterium that is commonly found on the skin and mucous membranes of warm-blooded animals and humans. It is a facultative anaerobe, which means it can grow in the presence or absence of oxygen.

Staphylococcus aureus is known to cause a wide range of infections, from mild skin infections such as pimples, impetigo, and furuncles (boils) to more severe and potentially life-threatening infections such as pneumonia, endocarditis, osteomyelitis, and sepsis. It can also cause food poisoning and toxic shock syndrome.

The bacterium is often resistant to multiple antibiotics, including methicillin, which has led to the emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains that are difficult to treat. Proper hand hygiene and infection control practices are critical in preventing the spread of Staphylococcus aureus and MRSA.

Pseudomonas infections are infections caused by the bacterium Pseudomonas aeruginosa or other species of the Pseudomonas genus. These bacteria are gram-negative, opportunistic pathogens that can cause various types of infections, including respiratory, urinary tract, gastrointestinal, dermatological, and bloodstream infections.

Pseudomonas aeruginosa is a common cause of healthcare-associated infections, particularly in patients with weakened immune systems, chronic lung diseases, or those who are hospitalized for extended periods. The bacteria can also infect wounds, burns, and medical devices such as catheters and ventilators.

Pseudomonas infections can be difficult to treat due to the bacteria's resistance to many antibiotics. Treatment typically involves the use of multiple antibiotics that are effective against Pseudomonas aeruginosa. In severe cases, intravenous antibiotics or even hospitalization may be necessary.

Prevention measures include good hand hygiene, contact precautions for patients with known Pseudomonas infections, and proper cleaning and maintenance of medical equipment.

Gram-positive bacteria are a type of bacteria that stain dark purple or blue when subjected to the Gram staining method, which is a common technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This staining method was developed by Hans Christian Gram in 1884.

The key characteristic that distinguishes Gram-positive bacteria from other types, such as Gram-negative bacteria, is the presence of a thick layer of peptidoglycan in their cell walls, which retains the crystal violet stain used in the Gram staining process. Additionally, Gram-positive bacteria lack an outer membrane found in Gram-negative bacteria.

Examples of Gram-positive bacteria include Staphylococcus aureus, Streptococcus pyogenes, and Bacillus subtilis. Some Gram-positive bacteria can cause various human diseases, while others are beneficial or harmless.

Gram-negative bacterial infections refer to illnesses or diseases caused by Gram-negative bacteria, which are a group of bacteria that do not retain crystal violet dye during the Gram staining procedure used in microbiology. This characteristic is due to the structure of their cell walls, which contain a thin layer of peptidoglycan and an outer membrane composed of lipopolysaccharides (LPS), proteins, and phospholipids.

The LPS component of the outer membrane is responsible for the endotoxic properties of Gram-negative bacteria, which can lead to severe inflammatory responses in the host. Common Gram-negative bacterial pathogens include Escherichia coli (E. coli), Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Proteus mirabilis, among others.

Gram-negative bacterial infections can cause a wide range of clinical syndromes, such as pneumonia, urinary tract infections, bloodstream infections, meningitis, and soft tissue infections. The severity of these infections can vary from mild to life-threatening, depending on the patient's immune status, the site of infection, and the virulence of the bacterial strain.

Effective antibiotic therapy is crucial for treating Gram-negative bacterial infections, but the increasing prevalence of multidrug-resistant strains has become a significant global health concern. Therefore, accurate diagnosis and appropriate antimicrobial stewardship are essential to ensure optimal patient outcomes and prevent further spread of resistance.

DNA topoisomerases are enzymes that regulate the topological state of DNA during various cellular processes such as replication, transcription, and repair. They do this by introducing temporary breaks in the DNA strands and allowing the strands to rotate around each other, thereby relieving torsional stress and supercoiling. Topoisomerases are classified into two types: type I and type II.

Type II topoisomerases are further divided into two subtypes: type IIA and type IIB. These enzymes function by forming a covalent bond with the DNA strands, cleaving them, and then passing another segment of DNA through the break before resealing the original strands. This process allows for the removal of both positive and negative supercoils from DNA as well as the separation of interlinked circular DNA molecules (catenanes) or knotted DNA structures.

Type II topoisomerases are essential for cell viability, and their dysfunction has been linked to various human diseases, including cancer and neurodegenerative disorders. They have also emerged as important targets for the development of anticancer drugs that inhibit their activity and induce DNA damage leading to cell death. Examples of type II topoisomerase inhibitors include etoposide, doxorubicin, and mitoxantrone.

Ceftriaxone is a third-generation cephalosporin antibiotic, which is used to treat a wide range of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Ceftriaxone has a broad spectrum of activity and is effective against many gram-positive and gram-negative bacteria, including some that are resistant to other antibiotics.

Ceftriaxone is available in injectable form and is commonly used to treat serious infections such as meningitis, pneumonia, and sepsis. It is also used to prevent infections after surgery or trauma. The drug is generally well-tolerated, but it can cause side effects such as diarrhea, nausea, vomiting, and rash. In rare cases, it may cause serious side effects such as anaphylaxis, kidney damage, and seizures.

It's important to note that Ceftriaxone should be used only under the supervision of a healthcare professional, and that it is not recommended for use in individuals with a history of allergic reactions to cephalosporins or penicillins. Additionally, as with all antibiotics, it should be taken as directed and for the full duration of the prescribed course of treatment, even if symptoms improve before the treatment is finished.

Salmonella Paratyphi A is a bacterium that causes a type of enteric fever known as Paratyphoid fever. It's a gram-negative, rod-shaped bacterium that is motile and non-spore forming. This bacterium is transmitted through the fecal-oral route, often through contaminated food or water. The incubation period for paratyphoid fever can range from 5 to 10 days. Symptoms include high fever, headache, abdominal pain, and sometimes a rash. Paratyphoid fever is a systemic infection that can affect various organs in the body, including the liver, spleen, and bone marrow. It's treated with antibiotics, and prevention measures include good hygiene practices, safe food handling, and vaccination for high-risk populations.

Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.

Ceftazidime is a third-generation cephalosporin antibiotic, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, leading to bacterial cell death. Ceftazidime has a broad spectrum of activity and is effective against many Gram-negative and some Gram-positive bacteria.

It is often used to treat serious infections such as pneumonia, urinary tract infections, and sepsis, particularly when they are caused by antibiotic-resistant bacteria. Ceftazidime is also commonly used in combination with other antibiotics to treat complicated abdominal infections, bone and joint infections, and hospital-acquired pneumonia.

Like all antibiotics, ceftazidime can cause side effects, including diarrhea, nausea, vomiting, and allergic reactions. It may also affect the kidneys and should be used with caution in patients with impaired renal function. Ceftazidime is available in both intravenous (IV) and oral forms.

Streptococcus pneumoniae, also known as the pneumococcus, is a gram-positive, alpha-hemolytic bacterium frequently found in the upper respiratory tract of healthy individuals. It is a leading cause of community-acquired pneumonia and can also cause other infectious diseases such as otitis media (ear infection), sinusitis, meningitis, and bacteremia (bloodstream infection). The bacteria are encapsulated, and there are over 90 serotypes based on variations in the capsular polysaccharide. Some serotypes are more virulent or invasive than others, and the polysaccharide composition is crucial for vaccine development. S. pneumoniae infection can be treated with antibiotics, but the emergence of drug-resistant strains has become a significant global health concern.

Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae, also known as "gono" bacteria. It can infect various parts of the body including the genitals, rectum, and throat. The bacteria are typically transmitted through sexual contact with an infected person.

Symptoms may vary but often include abnormal discharge from the genitals or rectum, painful or burning sensations during urination, and in women, vaginal bleeding between periods. However, many people with gonorrhea do not develop symptoms, making it essential to get tested regularly if you are sexually active with multiple partners or have unprotected sex.

If left untreated, gonorrhea can lead to severe complications such as pelvic inflammatory disease (PID) in women and epididymitis in men, which may result in infertility. In rare cases, it can spread to the bloodstream and cause life-threatening conditions like sepsis.

Gonorrhea is curable with appropriate antibiotic treatment; however, drug-resistant strains of the bacteria have emerged, making accurate diagnosis and effective treatment increasingly challenging. Prevention methods include using condoms during sexual activity and practicing safe sex habits.

Neisseria gonorrhoeae is a species of gram-negative, aerobic diplococcus that is the etiologic agent of gonorrhea, a sexually transmitted infection. It is commonly found in the mucous membranes of the reproductive tract, including the cervix, urethra, and rectum, as well as the throat and eyes. The bacterium can cause a range of symptoms, including discharge, burning during urination, and, in women, abnormal menstrual bleeding. If left untreated, it can lead to more serious complications, such as pelvic inflammatory disease and infertility. It is important to note that N. gonorrhoeae has developed resistance to many antibiotics over time, making treatment more challenging. A culture or nucleic acid amplification test (NAAT) is used for the diagnosis of this infection.

Salmonella typhi is a bacterium that causes typhoid fever, a severe and sometimes fatal infectious disease. It is a human-specific pathogen, which means it only infects humans and is not carried in animals or birds. The bacteria are spread through the fecal-oral route, often through contaminated food or water. Once ingested, Salmonella typhi can invade the intestinal tract, causing symptoms such as high fever, headache, abdominal pain, constipation, and rose-colored spots on the chest. If left untreated, typhoid fever can lead to serious complications, including intestinal perforation, bacteremia, and death.

Typhoid fever is an acute illness caused by the bacterium Salmonella enterica serovar Typhi. It is characterized by sustained fever, headache, constipation or diarrhea, rose-colored rash (in some cases), abdominal pain, and weakness. The bacteria are spread through contaminated food, water, or direct contact with an infected person's feces. If left untreated, typhoid fever can lead to severe complications and even be fatal. It is diagnosed through blood, stool, or urine tests and treated with antibiotics. Vaccination is available for prevention.

A "colony count" is a method used to estimate the number of viable microorganisms, such as bacteria or fungi, in a sample. In this technique, a known volume of the sample is spread onto the surface of a solid nutrient medium in a petri dish and then incubated under conditions that allow the microorganisms to grow and form visible colonies. Each colony that grows on the plate represents an individual cell (or small cluster of cells) from the original sample that was able to divide and grow under the given conditions. By counting the number of colonies that form, researchers can make a rough estimate of the concentration of microorganisms in the original sample.

The term "microbial" simply refers to microscopic organisms, such as bacteria, fungi, or viruses. Therefore, a "colony count, microbial" is a general term that encompasses the use of colony counting techniques to estimate the number of any type of microorganism in a sample.

Colony counts are used in various fields, including medical research, food safety testing, and environmental monitoring, to assess the levels of contamination or the effectiveness of disinfection procedures. However, it is important to note that colony counts may not always provide an accurate measure of the total number of microorganisms present in a sample, as some cells may be injured or unable to grow under the conditions used for counting. Additionally, some microorganisms may form clusters or chains that can appear as single colonies, leading to an overestimation of the true cell count.

Aerobic bacteria are a type of bacteria that require oxygen to live and grow. These bacteria use oxygen as the final electron acceptor in their respiratory chain to generate energy in the form of ATP (adenosine triphosphate). Aerobic bacteria can be found in various environments, including soil, water, and the air, as well as on the surfaces of living things. Some examples of aerobic bacteria include species of Pseudomonas, Bacillus, and Staphylococcus.

It's worth noting that some bacteria can switch between aerobic and anaerobic metabolism depending on the availability of oxygen. These bacteria are called facultative anaerobes. In contrast, obligate anaerobes are bacteria that cannot tolerate oxygen and will die in its presence.

Urinary Tract Infections (UTIs) are defined as the presence of pathogenic microorganisms, typically bacteria, in any part of the urinary system, which includes the kidneys, ureters, bladder, and urethra, resulting in infection and inflammation. The majority of UTIs are caused by Escherichia coli (E. coli) bacteria, but other organisms such as Klebsiella, Proteus, Staphylococcus saprophyticus, and Enterococcus can also cause UTIs.

UTIs can be classified into two types based on the location of the infection:

1. Lower UTI or bladder infection (cystitis): This type of UTI affects the bladder and urethra. Symptoms may include a frequent and urgent need to urinate, pain or burning during urination, cloudy or strong-smelling urine, and discomfort in the lower abdomen or back.

2. Upper UTI or kidney infection (pyelonephritis): This type of UTI affects the kidneys and can be more severe than a bladder infection. Symptoms may include fever, chills, nausea, vomiting, and pain in the flanks or back.

UTIs are more common in women than men due to their shorter urethra, which makes it easier for bacteria to reach the bladder. Other risk factors for UTIs include sexual activity, use of diaphragms or spermicides, urinary catheterization, diabetes, and weakened immune systems.

UTIs are typically diagnosed through a urinalysis and urine culture to identify the causative organism and determine the appropriate antibiotic treatment. In some cases, imaging studies such as ultrasound or CT scan may be necessary to evaluate for any underlying abnormalities in the urinary tract.

Bacterial infections are caused by the invasion and multiplication of bacteria in or on tissues of the body. These infections can range from mild, like a common cold, to severe, such as pneumonia, meningitis, or sepsis. The symptoms of a bacterial infection depend on the type of bacteria invading the body and the area of the body that is affected.

Bacteria are single-celled microorganisms that can live in many different environments, including in the human body. While some bacteria are beneficial to humans and help with digestion or protect against harmful pathogens, others can cause illness and disease. When bacteria invade the body, they can release toxins and other harmful substances that damage tissues and trigger an immune response.

Bacterial infections can be treated with antibiotics, which work by killing or inhibiting the growth of bacteria. However, it is important to note that misuse or overuse of antibiotics can lead to antibiotic resistance, making treatment more difficult. It is also essential to complete the full course of antibiotics as prescribed, even if symptoms improve, to ensure that all bacteria are eliminated and reduce the risk of recurrence or development of antibiotic resistance.

Anaerobic bacteria are a type of bacteria that do not require oxygen to grow and survive. Instead, they can grow in environments that have little or no oxygen. Some anaerobic bacteria can even be harmed or killed by exposure to oxygen. These bacteria play important roles in many natural processes, such as decomposition and the breakdown of organic matter in the digestive system. However, some anaerobic bacteria can also cause disease in humans and animals, particularly when they infect areas of the body that are normally oxygen-rich. Examples of anaerobic bacterial infections include tetanus, gas gangrene, and dental abscesses.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Gentamicin is an antibiotic that belongs to the class of aminoglycosides. It is used to treat various types of bacterial infections, including:

* Gram-negative bacterial infections, such as those caused by Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis
* Certain Gram-positive bacterial infections, such as those caused by Staphylococcus aureus and Streptococcus pyogenes

Gentamicin works by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death. It is typically given via injection (intramuscularly or intravenously) and is often used in combination with other antibiotics to treat serious infections.

Like all aminoglycosides, gentamicin can cause kidney damage and hearing loss, especially when used for long periods of time or at high doses. Therefore, monitoring of drug levels and renal function is recommended during treatment.

Rifampin is an antibiotic medication that belongs to the class of drugs known as rifamycins. It works by inhibiting bacterial DNA-dependent RNA polymerase, thereby preventing bacterial growth and multiplication. Rifampin is used to treat a variety of infections caused by bacteria, including tuberculosis, Haemophilus influenzae, Neisseria meningitidis, and Legionella pneumophila. It is also used to prevent meningococcal disease in people who have been exposed to the bacteria.

Rifampin is available in various forms, including tablets, capsules, and injectable solutions. The medication is usually taken two to four times a day, depending on the type and severity of the infection being treated. Rifampin may be given alone or in combination with other antibiotics.

It is important to note that rifampin can interact with several other medications, including oral contraceptives, anticoagulants, and anti-seizure drugs, among others. Therefore, it is essential to inform your healthcare provider about all the medications you are taking before starting treatment with rifampin.

Rifampin may cause side effects such as nausea, vomiting, diarrhea, dizziness, headache, and changes in the color of urine, tears, sweat, and saliva to a reddish-orange color. These side effects are usually mild and go away on their own. However, if they persist or become bothersome, it is important to consult your healthcare provider.

In summary, rifampin is an antibiotic medication used to treat various bacterial infections and prevent meningococcal disease. It works by inhibiting bacterial DNA-dependent RNA polymerase, preventing bacterial growth and multiplication. Rifampin may interact with several other medications, and it can cause side effects such as nausea, vomiting, diarrhea, dizziness, headache, and changes in the color of body fluids.

Trimethoprim-sulfamethoxazole combination is an antibiotic medication used to treat various bacterial infections. It contains two active ingredients: trimethoprim and sulfamethoxazole, which work together to inhibit the growth of bacteria by interfering with their ability to synthesize folic acid, a vital component for their survival.

Trimethoprim is a bacteriostatic agent that inhibits dihydrofolate reductase, an enzyme needed for bacterial growth, while sulfamethoxazole is a bacteriostatic sulfonamide that inhibits the synthesis of tetrahydrofolate by blocking the action of the enzyme bacterial dihydropteroate synthase. The combination of these two agents produces a synergistic effect, increasing the overall antibacterial activity of the medication.

Trimethoprim-sulfamethoxazole is commonly used to treat urinary tract infections, middle ear infections, bronchitis, traveler's diarrhea, and pneumocystis pneumonia (PCP), a severe lung infection that can occur in people with weakened immune systems. It is also used as a prophylactic treatment to prevent PCP in individuals with HIV/AIDS or other conditions that compromise the immune system.

As with any medication, trimethoprim-sulfamethoxazole combination can have side effects and potential risks, including allergic reactions, skin rashes, gastrointestinal symptoms, and blood disorders. It is essential to follow the prescribing physician's instructions carefully and report any adverse reactions promptly.

Paratyphoid fever is an acute infectious disease, similar to typhoid fever, caused by the Salmonella enterica serotype Paratyphi bacteria. The illness is characterized by fever, headache, abdominal pain, and occasionally rash. It's spread through contaminated food and water, and it primarily affects the intestinal tract and sometimes the bloodstream. Symptoms typically appear within a week of exposure and may include sustained fever, malaise, muscle aches, headache, cough, and constipation or diarrhea. Paratyphoid fever can be prevented by practicing good sanitation and hygiene, such as frequent hand washing, and is treated with antibiotics.

Imipenem is an antibiotic medication that belongs to the class of carbapenems. It is used to treat various types of bacterial infections, including pneumonia, sepsis, and skin infections. Imipenem works by inhibiting the synthesis of bacterial cell walls, leading to bacterial death.

Imipenem is often combined with another medication called cilastatin, which helps to prevent the breakdown of imipenem in the body and increase its effectiveness. The combination of imipenem and cilastatin is available under the brand name Primaxin.

Like other antibiotics, imipenem should be used with caution and only when necessary, as overuse can lead to antibiotic resistance. It is important to follow the prescribing physician's instructions carefully and complete the full course of treatment, even if symptoms improve before the medication is finished.

Amikacin is a type of antibiotic known as an aminoglycoside, which is used to treat various bacterial infections. It works by binding to the 30S subunit of the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death. Amikacin is often used to treat serious infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. It may be given intravenously or intramuscularly, depending on the severity and location of the infection. As with all antibiotics, amikacin should be used judiciously to prevent the development of antibiotic resistance.

Bacterial eye infections, also known as bacterial conjunctivitis or bacterial keratitis, are caused by the invasion of bacteria into the eye. The most common types of bacteria that cause these infections include Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.

Bacterial conjunctivitis is an inflammation of the conjunctiva, the thin membrane that covers the white part of the eye and the inner surface of the eyelids. Symptoms include redness, swelling, pain, discharge, and a gritty feeling in the eye. Bacterial keratitis is an infection of the cornea, the clear front part of the eye. Symptoms include severe pain, sensitivity to light, tearing, and decreased vision.

Bacterial eye infections are typically treated with antibiotic eye drops or ointments. It is important to seek medical attention promptly if you suspect a bacterial eye infection, as untreated infections can lead to serious complications such as corneal ulcers and vision loss. Preventive measures include good hygiene practices, such as washing your hands frequently and avoiding touching or rubbing your eyes.

Bacteremia is the presence of bacteria in the bloodstream. It is a medical condition that occurs when bacteria from another source, such as an infection in another part of the body, enter the bloodstream. Bacteremia can cause symptoms such as fever, chills, and rapid heart rate, and it can lead to serious complications such as sepsis if not treated promptly with antibiotics.

Bacteremia is often a result of an infection elsewhere in the body that allows bacteria to enter the bloodstream. This can happen through various routes, such as during medical procedures, intravenous (IV) drug use, or from infected wounds or devices that come into contact with the bloodstream. In some cases, bacteremia may also occur without any obvious source of infection.

It is important to note that not all bacteria in the bloodstream cause harm, and some people may have bacteria in their blood without showing any symptoms. However, if bacteria in the bloodstream multiply and cause an immune response, it can lead to bacteremia and potentially serious complications.

Azithromycin is a widely used antibiotic drug that belongs to the class of macrolides. It works by inhibiting bacterial protein synthesis, which leads to the death of susceptible bacteria. This medication is active against a broad range of gram-positive and gram-negative bacteria, atypical bacteria, and some parasites.

Azithromycin is commonly prescribed to treat various bacterial infections, such as:

1. Respiratory tract infections, including pneumonia, bronchitis, and sinusitis
2. Skin and soft tissue infections
3. Sexually transmitted diseases, like chlamydia
4. Otitis media (middle ear infection)
5. Traveler's diarrhea

The drug is available in various forms, including tablets, capsules, suspension, and intravenous solutions. The typical dosage for adults ranges from 250 mg to 500 mg per day, depending on the type and severity of the infection being treated.

Like other antibiotics, azithromycin should be used judiciously to prevent antibiotic resistance. It is essential to complete the full course of treatment as prescribed by a healthcare professional, even if symptoms improve before finishing the medication.

Staphylococcal infections are a type of infection caused by Staphylococcus bacteria, which are commonly found on the skin and nose of healthy people. However, if they enter the body through a cut, scratch, or other wound, they can cause an infection.

There are several types of Staphylococcus bacteria, but the most common one that causes infections is Staphylococcus aureus. These infections can range from minor skin infections such as pimples, boils, and impetigo to serious conditions such as pneumonia, bloodstream infections, and toxic shock syndrome.

Symptoms of staphylococcal infections depend on the type and severity of the infection. Treatment typically involves antibiotics, either topical or oral, depending on the severity and location of the infection. In some cases, hospitalization may be necessary for more severe infections. It is important to note that some strains of Staphylococcus aureus have developed resistance to certain antibiotics, making them more difficult to treat.

In the context of pharmacology, "half-life" refers to the time it takes for the concentration or amount of a drug in the body to be reduced by half during its elimination phase. This is typically influenced by factors such as metabolism and excretion rates of the drug. It's a key factor in determining dosage intervals and therapeutic effectiveness of medications, as well as potential side effects or toxicity risks.

A Serum Bactericidal Test (SBT) is a laboratory test used to determine the ability of a patient's serum to kill specific bacteria. The test measures the concentration of complement and antibodies in the serum that can contribute to bacterial killing. In this test, a standardized quantity of bacteria is mixed with serial dilutions of the patient's serum and incubated for a set period. After incubation, the mixture is plated on agar media, and the number of surviving bacteria is counted after a suitable incubation period. The bactericidal titer is defined as the reciprocal of the highest dilution of serum that kills 99.9% of the initial inoculum.

The SBT is often used to evaluate the efficacy of antibiotic therapy, assess immune function, and diagnose infections caused by bacteria with reduced susceptibility to complement-mediated killing. The test can also be used to monitor the response to immunotherapy or vaccination and to identify patients at risk for recurrent infections due to impaired serum bactericidal activity.

It is important to note that the SBT has some limitations, including its variability between laboratories, the need for specialized equipment and expertise, and the potential for false-positive or false-negative results. Therefore, the test should be interpreted in conjunction with other clinical and laboratory data.

Ampicillin is a penicillin-type antibiotic used to treat a wide range of bacterial infections. It works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. This causes the bacterial cells to become unstable and eventually die.

The medical definition of Ampicillin is:

"A semi-synthetic penicillin antibiotic, derived from the Penicillium mold. It is used to treat a variety of infections caused by susceptible gram-positive and gram-negative bacteria. Ampicillin is effective against both aerobic and anaerobic organisms. It is commonly used to treat respiratory tract infections, urinary tract infections, meningitis, and endocarditis."

It's important to note that Ampicillin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or other bacteria that have developed resistance to penicillins. Additionally, overuse of antibiotics like Ampicillin can lead to the development of antibiotic resistance, which is a significant public health concern.

"Klebsiella pneumoniae" is a medical term that refers to a type of bacteria belonging to the family Enterobacteriaceae. It's a gram-negative, encapsulated, non-motile, rod-shaped bacterium that can be found in various environments, including soil, water, and the gastrointestinal tracts of humans and animals.

"Klebsiella pneumoniae" is an opportunistic pathogen that can cause a range of infections, particularly in individuals with weakened immune systems or underlying medical conditions. It's a common cause of healthcare-associated infections, such as pneumonia, urinary tract infections, bloodstream infections, and wound infections.

The bacterium is known for its ability to produce a polysaccharide capsule that makes it resistant to phagocytosis by white blood cells, allowing it to evade the host's immune system. Additionally, "Klebsiella pneumoniae" has developed resistance to many antibiotics, making infections caused by this bacterium difficult to treat and a growing public health concern.

Escherichia coli (E. coli) infections refer to illnesses caused by the bacterium E. coli, which can cause a range of symptoms depending on the specific strain and site of infection. The majority of E. coli strains are harmless and live in the intestines of healthy humans and animals. However, some strains, particularly those that produce Shiga toxins, can cause severe illness.

E. coli infections can occur through various routes, including contaminated food or water, person-to-person contact, or direct contact with animals or their environments. Common symptoms of E. coli infections include diarrhea (often bloody), abdominal cramps, nausea, and vomiting. In severe cases, complications such as hemolytic uremic syndrome (HUS) can occur, which may lead to kidney failure and other long-term health problems.

Preventing E. coli infections involves practicing good hygiene, cooking meats thoroughly, avoiding cross-contamination of food during preparation, washing fruits and vegetables before eating, and avoiding unpasteurized dairy products and juices. Prompt medical attention is necessary if symptoms of an E. coli infection are suspected to prevent potential complications.

The term "Area Under Curve" (AUC) is commonly used in the medical field, particularly in the analysis of diagnostic tests or pharmacokinetic studies. The AUC refers to the mathematical calculation of the area between a curve and the x-axis in a graph, typically representing a concentration-time profile.

In the context of diagnostic tests, the AUC is used to evaluate the performance of a test by measuring the entire two-dimensional area underneath the receiver operating characteristic (ROC) curve, which plots the true positive rate (sensitivity) against the false positive rate (1-specificity) at various threshold settings. The AUC ranges from 0 to 1, where a higher AUC indicates better test performance:

* An AUC of 0.5 suggests that the test is no better than chance.
* An AUC between 0.7 and 0.8 implies moderate accuracy.
* An AUC between 0.8 and 0.9 indicates high accuracy.
* An AUC greater than 0.9 signifies very high accuracy.

In pharmacokinetic studies, the AUC is used to assess drug exposure over time by calculating the area under a plasma concentration-time curve (AUC(0-t) or AUC(0-\∞)) following drug administration. This value can help determine dosing regimens and evaluate potential drug interactions:

* AUC(0-t): Represents the area under the plasma concentration-time curve from time zero to the last measurable concentration (t).
* AUC(0-\∞): Refers to the area under the plasma concentration-time curve from time zero to infinity, which estimates total drug exposure.

Salmonella infections, also known as salmonellosis, are a type of foodborne illness caused by the Salmonella bacterium. These bacteria can be found in the intestinal tracts of humans, animals, and birds, especially poultry. People typically get salmonella infections from consuming contaminated foods or water, or through contact with infected animals or their feces. Common sources of Salmonella include raw or undercooked meat, poultry, eggs, and milk products; contaminated fruits and vegetables; and improperly prepared or stored food.

Symptoms of salmonella infections usually begin within 12 to 72 hours after exposure and can include diarrhea, abdominal cramps, fever, nausea, vomiting, and headache. Most people recover from salmonella infections without treatment within four to seven days, although some cases may be severe or even life-threatening, especially in young children, older adults, pregnant women, and people with weakened immune systems. In rare cases, Salmonella can spread from the intestines to the bloodstream and cause serious complications such as meningitis, endocarditis, and arthritis.

Prevention measures include proper food handling, cooking, and storage practices; washing hands thoroughly after using the bathroom, changing diapers, or touching animals; avoiding cross-contamination of foods during preparation; and using pasteurized dairy products and eggs. If you suspect that you have a Salmonella infection, it is important to seek medical attention promptly to prevent complications and reduce the risk of spreading the infection to others.

Cefuroxime is a type of antibiotic known as a cephalosporin, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria are unable to grow and multiply, and are eventually destroyed by the body's immune system.

Cefuroxime is effective against many different types of bacteria, including both Gram-positive and Gram-negative organisms. It is often used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bone and joint infections.

Like all antibiotics, cefuroxime should be used only under the direction of a healthcare provider, and it is important to take the full course of treatment as prescribed, even if symptoms improve before the medication is finished. Misuse of antibiotics can lead to the development of drug-resistant bacteria, which are more difficult to treat and can pose a serious threat to public health.

Cefotaxime is a third-generation cephalosporin antibiotic, which is used to treat a variety of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Cefotaxime has a broad spectrum of activity and is effective against many Gram-positive and Gram-negative bacteria, including some that are resistant to other antibiotics.

Cefotaxime is often used to treat serious infections such as pneumonia, meningitis, and sepsis. It may also be used to prevent infections during surgery or in people with weakened immune systems. The drug is administered intravenously or intramuscularly, and its dosage depends on the type and severity of the infection being treated.

Like all antibiotics, cefotaxime can cause side effects, including diarrhea, nausea, vomiting, and rash. In rare cases, it may cause serious allergic reactions or damage to the kidneys or liver. It is important to follow the prescribing physician's instructions carefully when taking this medication.

Cephalosporins are a class of antibiotics that are derived from the fungus Acremonium, originally isolated from seawater and cow dung. They have a similar chemical structure to penicillin and share a common four-membered beta-lactam ring in their molecular structure.

Cephalosporins work by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. They are broad-spectrum antibiotics, meaning they are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

There are several generations of cephalosporins, each with different spectra of activity and pharmacokinetic properties. The first generation cephalosporins have a narrow spectrum of activity and are primarily used to treat infections caused by susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae.

Second-generation cephalosporins have an expanded spectrum of activity that includes some Gram-negative organisms, such as Escherichia coli and Haemophilus influenzae. Third-generation cephalosporins have even broader spectra of activity and are effective against many resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae.

Fourth-generation cephalosporins have activity against both Gram-positive and Gram-negative organisms, including some that are resistant to other antibiotics. They are often reserved for the treatment of serious infections caused by multidrug-resistant bacteria.

Cephalosporins are generally well tolerated, but like penicillin, they can cause allergic reactions in some individuals. Cross-reactivity between cephalosporins and penicillin is estimated to occur in 5-10% of patients with a history of penicillin allergy. Other potential adverse effects include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), neurotoxicity, and nephrotoxicity.

Enterobacteriaceae is a family of gram-negative, rod-shaped bacteria that are commonly found in the intestines of humans and animals. Many species within this family are capable of causing various types of infections, particularly in individuals with weakened immune systems. Some common examples of Enterobacteriaceae include Escherichia coli (E. coli), Klebsiella pneumoniae, Proteus mirabilis, and Salmonella enterica.

These bacteria are typically characterized by their ability to ferment various sugars and produce acid and gas as byproducts. They can also be distinguished by their biochemical reactions, such as their ability to produce certain enzymes or resist specific antibiotics. Infections caused by Enterobacteriaceae can range from mild to severe, depending on the species involved and the overall health of the infected individual.

Some infections caused by Enterobacteriaceae include urinary tract infections, pneumonia, bloodstream infections, and foodborne illnesses. Proper hygiene, such as handwashing and safe food handling practices, can help prevent the spread of these bacteria and reduce the risk of infection.

Nitrofurantoin is an antibacterial medication used to treat urinary tract infections caused by susceptible strains of bacteria. According to the Medical Subject Headings (MeSH) of the National Library of Medicine, its medical definition is: "Antibacterial agent with nitrofuran ring and furazan moiety. It is used to treat urinary tract infections and is also used for prophylaxis of recurrent urinary tract infections."

Nitrofurantoin works by inhibiting bacterial DNA synthesis, leading to bacterial death. It is typically administered orally and is available under various brand names, such as Macrobid® and Furadantin®. The medication is generally well-tolerated; however, potential side effects include gastrointestinal symptoms (nausea, vomiting, diarrhea, or abdominal pain), headaches, dizziness, and pulmonary reactions. Rare but severe adverse events include peripheral neuropathy and hepatotoxicity.

It is essential to note that nitrofurantoin's effectiveness depends on the susceptibility of the infecting bacteria, and resistance has been reported in some cases. Therefore, it is crucial to consider local resistance patterns when prescribing this antibiotic.

Piperacillin is a type of antibiotic known as a semisynthetic penicillin that is used to treat a variety of infections caused by bacteria. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die.

Piperacillin has a broad spectrum of activity against both gram-positive and gram-negative bacteria, including many strains that are resistant to other antibiotics. It is often used in combination with other antibiotics, such as tazobactam, to increase its effectiveness against certain types of bacteria.

Piperacillin is typically administered intravenously in a hospital setting and is used to treat serious infections such as pneumonia, sepsis, and abdominal or urinary tract infections. As with all antibiotics, it should be used only when necessary and under the guidance of a healthcare professional to reduce the risk of antibiotic resistance.

Azlocillin is a semisynthetic antibiotic belonging to the class of extended-spectrum penicillins. It is derived from the basic penicillin structure and has an additional side chain that provides it with a broader spectrum of activity, including against many Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa.

Azlocillin works by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. It is commonly used in the treatment of severe intra-abdominal infections, urinary tract infections, and septicemia caused by susceptible organisms.

Like other antibiotics, azlocillin should be used with caution and only when necessary, as overuse can lead to the development of antibiotic resistance. It is important to note that individual patient responses to medications may vary, and healthcare providers should consider each patient's unique medical history and current health status before prescribing any medication.

Topoisomerase II inhibitors are a class of anticancer drugs that work by interfering with the enzyme topoisomerase II, which is essential for DNA replication and transcription. These inhibitors bind to the enzyme-DNA complex, preventing the relaxation of supercoiled DNA and causing DNA strand breaks. This results in the accumulation of double-stranded DNA breaks, which can lead to apoptosis (programmed cell death) in rapidly dividing cells, such as cancer cells. Examples of topoisomerase II inhibitors include etoposide, doxorubicin, and mitoxantrone.

Thienamycins are a group of antibiotics that are characterized by their beta-lactam structure. They belong to the class of carbapenems and are known for their broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria, including many that are resistant to other antibiotics. Thienamycins inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), which leads to bacterial cell death.

Thienamycin itself is not used clinically due to its instability, but several semi-synthetic derivatives of thienamycin have been developed and are used in the treatment of serious infections caused by multidrug-resistant bacteria. Examples of thienamycin derivatives include imipenem, meropenem, and ertapenem. These antibiotics are often reserved for the treatment of severe infections that are unresponsive to other antibiotics due to their potential to select for resistant bacteria and their high cost.

A drug interaction is the effect of combining two or more drugs, or a drug and another substance (such as food or alcohol), which can alter the effectiveness or side effects of one or both of the substances. These interactions can be categorized as follows:

1. Pharmacodynamic interactions: These occur when two or more drugs act on the same target organ or receptor, leading to an additive, synergistic, or antagonistic effect. For example, taking a sedative and an antihistamine together can result in increased drowsiness due to their combined depressant effects on the central nervous system.
2. Pharmacokinetic interactions: These occur when one drug affects the absorption, distribution, metabolism, or excretion of another drug. For example, taking certain antibiotics with grapefruit juice can increase the concentration of the antibiotic in the bloodstream, leading to potential toxicity.
3. Food-drug interactions: Some drugs may interact with specific foods, affecting their absorption, metabolism, or excretion. An example is the interaction between warfarin (a blood thinner) and green leafy vegetables, which can increase the risk of bleeding due to enhanced vitamin K absorption from the vegetables.
4. Drug-herb interactions: Some herbal supplements may interact with medications, leading to altered drug levels or increased side effects. For instance, St. John's Wort can decrease the effectiveness of certain antidepressants and oral contraceptives by inducing their metabolism.
5. Drug-alcohol interactions: Alcohol can interact with various medications, causing additive sedative effects, impaired judgment, or increased risk of liver damage. For example, combining alcohol with benzodiazepines or opioids can lead to dangerous levels of sedation and respiratory depression.

It is essential for healthcare providers and patients to be aware of potential drug interactions to minimize adverse effects and optimize treatment outcomes.

Penicillin resistance is the ability of certain bacteria to withstand the antibacterial effects of penicillin, a type of antibiotic. This occurs when these bacteria have developed mechanisms that prevent penicillin from binding to and inhibiting the function of their cell wall biosynthesis proteins, particularly the enzyme transpeptidase.

One common mechanism of penicillin resistance is the production of beta-lactamases, enzymes that can hydrolyze and inactivate the beta-lactam ring structure present in penicillin and other related antibiotics. Another mechanism involves alterations in the bacterial cell wall that prevent penicillin from binding to its target proteins.

Penicillin resistance is a significant concern in clinical settings, as it can limit treatment options for bacterial infections and may necessitate the use of more potent or toxic antibiotics. It is important to note that misuse or overuse of antibiotics can contribute to the development and spread of antibiotic-resistant bacteria, including those resistant to penicillin.

Bacteria are single-celled microorganisms that are among the earliest known life forms on Earth. They are typically characterized as having a cell wall and no membrane-bound organelles. The majority of bacteria have a prokaryotic organization, meaning they lack a nucleus and other membrane-bound organelles.

Bacteria exist in diverse environments and can be found in every habitat on Earth, including soil, water, and the bodies of plants and animals. Some bacteria are beneficial to their hosts, while others can cause disease. Beneficial bacteria play important roles in processes such as digestion, nitrogen fixation, and biogeochemical cycling.

Bacteria reproduce asexually through binary fission or budding, and some species can also exchange genetic material through conjugation. They have a wide range of metabolic capabilities, with many using organic compounds as their source of energy, while others are capable of photosynthesis or chemosynthesis.

Bacteria are highly adaptable and can evolve rapidly in response to environmental changes. This has led to the development of antibiotic resistance in some species, which poses a significant public health challenge. Understanding the biology and behavior of bacteria is essential for developing strategies to prevent and treat bacterial infections and diseases.

Erythromycin is a type of antibiotic known as a macrolide, which is used to treat various types of bacterial infections. It works by inhibiting the bacteria's ability to produce proteins, which are necessary for the bacteria to survive and multiply. Erythromycin is often used to treat respiratory tract infections, skin infections, and sexually transmitted diseases. It may also be used to prevent endocarditis (inflammation of the lining of the heart) in people at risk of this condition.

Erythromycin is generally considered safe for most people, but it can cause side effects such as nausea, vomiting, and diarrhea. It may also interact with other medications, so it's important to tell your doctor about all the drugs you are taking before starting erythromycin.

Like all antibiotics, erythromycin should only be used to treat bacterial infections, as it is not effective against viral infections such as the common cold or flu. Overuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

Trimethoprim is an antibiotic medication that is primarily used to treat bacterial infections. It works by inhibiting the bacterial enzyme dihydrofolate reductase, which is necessary for the synthesis of DNA and protein. This leads to bacterial cell death. Trimethoprim is often combined with sulfamethoxazole (a sulfonamide antibiotic) to create a more effective antibacterial therapy known as co-trimoxazole or TMP-SMX.

Medical Definition:
Trimethoprim is a synthetic antibacterial drug that selectively inhibits bacterial dihydrofolate reductase, an enzyme required for the synthesis of tetrahydrofolate, a cofactor involved in the biosynthesis of thymidine and purines. By blocking this essential pathway, trimethoprim disrupts bacterial DNA and protein synthesis, leading to bacteriostatic activity against many gram-positive and gram-negative bacteria. Trimethoprim is often combined with sulfamethoxazole (a sulfonamide antibiotic) to create a more effective antibacterial therapy known as co-trimoxazole or TMP-SMX, which inhibits two consecutive steps in the bacterial folate synthesis pathway.

Dry powder inhalers (DPIs) are medical devices used to administer medication in the form of a dry powder to the lungs. They are commonly used for treating respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

To use a DPI, the patient places a pre-measured dose of medication into the device and then inhales deeply through the mouthpiece. The force of the inhalation causes the powder to become airborne and disperse into small particles that can be easily inhaled into the lungs.

DPIs offer several advantages over other types of inhalers, such as metered-dose inhalers (MDIs). For example, DPIs do not require the use of a propellant to deliver the medication, which can make them more environmentally friendly and cost-effective. Additionally, because the medication is in powder form, it is less likely to deposit in the mouth and throat, reducing the risk of oral thrush and other side effects.

However, DPIs can be more difficult to use than MDIs, as they require a strong and sustained inhalation to properly disperse the medication. Patients may need to practice using their DPI regularly to ensure that they are able to use it effectively.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Penicillins are a group of antibiotics derived from the Penicillium fungus. They are widely used to treat various bacterial infections due to their bactericidal activity, which means they kill bacteria by interfering with the synthesis of their cell walls. The first penicillin, benzylpenicillin (also known as penicillin G), was discovered in 1928 by Sir Alexander Fleming. Since then, numerous semi-synthetic penicillins have been developed to expand the spectrum of activity and stability against bacterial enzymes that can inactivate these drugs.

Penicillins are classified into several groups based on their chemical structure and spectrum of activity:

1. Natural Penicillins (e.g., benzylpenicillin, phenoxymethylpenicillin): These have a narrow spectrum of activity, mainly targeting Gram-positive bacteria such as streptococci and staphylococci. However, they are susceptible to degradation by beta-lactamase enzymes produced by some bacteria.
2. Penicillinase-resistant Penicillins (e.g., methicillin, oxacillin, nafcillin): These penicillins resist degradation by certain bacterial beta-lactamases and are primarily used to treat infections caused by staphylococci, including methicillin-susceptible Staphylococcus aureus (MSSA).
3. Aminopenicillins (e.g., ampicillin, amoxicillin): These penicillins have an extended spectrum of activity compared to natural penicillins, including some Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae. However, they are still susceptible to degradation by many beta-lactamases.
4. Antipseudomonal Penicillins (e.g., carbenicillin, ticarcillin): These penicillins have activity against Pseudomonas aeruginosa and other Gram-negative bacteria with increased resistance to other antibiotics. They are often combined with beta-lactamase inhibitors such as clavulanate or tazobactam to protect them from degradation.
5. Extended-spectrum Penicillins (e.g., piperacillin): These penicillins have a broad spectrum of activity, including many Gram-positive and Gram-negative bacteria. They are often combined with beta-lactamase inhibitors to protect them from degradation.

Penicillins are generally well-tolerated antibiotics; however, they can cause allergic reactions in some individuals, ranging from mild skin rashes to life-threatening anaphylaxis. Cross-reactivity between different penicillin classes and other beta-lactam antibiotics (e.g., cephalosporins) is possible but varies depending on the specific drugs involved.

Vancomycin is an antibiotic that belongs to the glycopeptide class. It is primarily used to treat severe infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Vancomycin works by inhibiting the synthesis of bacterial cell walls. It is usually administered intravenously in a hospital setting due to its potential nephrotoxicity and ototoxicity. The medical definition of 'Vancomycin' can be summarized as:

"A glycopeptide antibiotic used to treat severe infections caused by Gram-positive bacteria, particularly those that are resistant to other antibiotics. It inhibits bacterial cell wall synthesis and is administered intravenously due to its potential nephrotoxicity and ototoxicity."

Keratitis is a medical condition that refers to inflammation of the cornea, which is the clear, dome-shaped surface at the front of the eye. The cornea plays an essential role in focusing vision, and any damage or infection can cause significant visual impairment. Keratitis can result from various causes, including bacterial, viral, fungal, or parasitic infections, as well as trauma, allergies, or underlying medical conditions such as dry eye syndrome. Symptoms of keratitis may include redness, pain, tearing, sensitivity to light, blurred vision, and a feeling of something foreign in the eye. Treatment for keratitis depends on the underlying cause but typically includes antibiotics, antivirals, or anti-fungal medications, as well as measures to alleviate symptoms and promote healing.

Doxycycline is a broad-spectrum antibiotic, which is a type of medication used to treat infections caused by bacteria and other microorganisms. It belongs to the tetracycline class of antibiotics. Doxycycline works by inhibiting the production of proteins that bacteria need to survive and multiply.

Doxycycline is used to treat a wide range of bacterial infections, including respiratory infections, skin infections, urinary tract infections, sexually transmitted diseases, and severe acne. It is also used to prevent malaria in travelers who are visiting areas where malaria is common.

Like all antibiotics, doxycycline should be taken exactly as directed by a healthcare professional. Misuse of antibiotics can lead to the development of drug-resistant bacteria, which can make infections harder to treat in the future.

It's important to note that doxycycline can cause photosensitivity, so it is recommended to avoid prolonged sun exposure and use sun protection while taking this medication. Additionally, doxycycline should not be taken during pregnancy or by children under the age of 8 due to potential dental and bone development issues.

Anti-infective agents for the urinary tract are medications used to prevent or treat infections caused by microorganisms (such as bacteria, fungi, or viruses) in the urinary system. These agents can be administered locally (for example, via catheter instillation) or systemically (orally or intravenously).

Common classes of anti-infective agents used for urinary tract infections include:

1. Antibiotics: These are the most commonly prescribed class of anti-infectives for urinary tract infections. They target and kill or inhibit the growth of bacteria responsible for the infection. Common antibiotics used for this purpose include trimethoprim-sulfamethoxazole, nitrofurantoin, ciprofloxacin, and fosfomycin.
2. Antifungals: These medications are used to treat fungal urinary tract infections (UTIs). Common antifungal agents include fluconazole, amphotericin B, and nystatin.
3. Antivirals: Although rare, viral UTIs can occur, and antiviral medications may be prescribed to treat them. Examples of antiviral agents used for urinary tract infections include acyclovir and valacyclovir.

It is essential to consult a healthcare professional for an accurate diagnosis and appropriate treatment for any suspected urinary tract infection. Improper use or misuse of anti-infective agents can lead to antibiotic resistance, making future treatments more challenging.

Cross infection, also known as cross-contamination, is the transmission of infectious agents or diseases between patients in a healthcare setting. This can occur through various means such as contaminated equipment, surfaces, hands of healthcare workers, or the air. It is an important concern in medical settings and measures are taken to prevent its occurrence, including proper hand hygiene, use of personal protective equipment (PPE), environmental cleaning and disinfection, and safe injection practices.

Tobramycin is an aminoglycoside antibiotic used to treat various types of bacterial infections. According to the Medical Subject Headings (MeSH) terminology of the National Library of Medicine (NLM), the medical definition of Tobramycin is:

"A semi-synthetic modification of the aminoglycoside antibiotic, NEOMYCIN, that retains its antimicrobial activity but has less nephrotoxic and neurotoxic side effects. Tobramycin is used in the treatment of serious gram-negative infections, especially Pseudomonas infections in patients with cystic fibrosis."

Tobramycin works by binding to the 30S ribosomal subunit of bacterial cells, inhibiting protein synthesis and ultimately leading to bacterial cell death. It is commonly used to treat severe infections caused by susceptible strains of gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Serratia marcescens, and Enterobacter species.

Tobramycin is available in various formulations, such as injectable solutions, ophthalmic ointments, and inhaled powder for nebulization. The choice of formulation depends on the type and location of the infection being treated. As with any antibiotic, it's essential to use Tobramycin appropriately and under medical supervision to minimize the risk of antibiotic resistance and potential side effects.

Tetracycline is a broad-spectrum antibiotic, which is used to treat various bacterial infections. It works by preventing the growth and multiplication of bacteria. It is a part of the tetracycline class of antibiotics, which also includes doxycycline, minocycline, and others.

Tetracycline is effective against a wide range of gram-positive and gram-negative bacteria, as well as some atypical organisms such as rickettsia, chlamydia, mycoplasma, and spirochetes. It is commonly used to treat respiratory infections, skin infections, urinary tract infections, sexually transmitted diseases, and other bacterial infections.

Tetracycline is available in various forms, including tablets, capsules, and liquid solutions. It should be taken orally with a full glass of water, and it is recommended to take it on an empty stomach, at least one hour before or two hours after meals. The drug can cause tooth discoloration in children under the age of 8, so it is generally not recommended for use in this population.

Like all antibiotics, tetracycline should be used only to treat bacterial infections and not viral infections, such as the common cold or flu. Overuse or misuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

Intravenous injections are a type of medical procedure where medication or fluids are administered directly into a vein using a needle and syringe. This route of administration is also known as an IV injection. The solution injected enters the patient's bloodstream immediately, allowing for rapid absorption and onset of action. Intravenous injections are commonly used to provide quick relief from symptoms, deliver medications that are not easily absorbed by other routes, or administer fluids and electrolytes in cases of dehydration or severe illness. It is important that intravenous injections are performed using aseptic technique to minimize the risk of infection.

Gram-positive bacterial infections refer to illnesses or diseases caused by Gram-positive bacteria, which are a group of bacteria that turn purple when stained using the Gram stain method. This staining technique is used in microbiology to differentiate between two main types of bacteria based on their cell wall composition.

Gram-positive bacteria have a thick layer of peptidoglycan in their cell walls, which retains the crystal violet stain used in the Gram staining process. Some common examples of Gram-positive bacteria include Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis.

Gram-positive bacterial infections can range from mild skin infections to severe and life-threatening conditions such as pneumonia, meningitis, and sepsis. The symptoms of these infections depend on the type of bacteria involved and the location of the infection in the body. Treatment typically involves the use of antibiotics that are effective against Gram-positive bacteria, such as penicillin, vancomycin, or clindamycin. However, the emergence of antibiotic resistance among Gram-positive bacteria is a growing concern and can complicate treatment in some cases.

"Methicillin resistance" is a term used in medicine to describe the resistance of certain bacteria to the antibiotic methicillin and other related antibiotics, such as oxacillin and nafcillin. This type of resistance is most commonly associated with Staphylococcus aureus (MRSA) and coagulase-negative staphylococci (MRCoNS) bacteria.

Bacteria that are methicillin-resistant have acquired the ability to produce an additional penicillin-binding protein, known as PBP2a or PBP2'', which has a low affinity for beta-lactam antibiotics, including methicillin. This results in the bacteria being able to continue growing and dividing despite the presence of these antibiotics, making infections caused by these bacteria more difficult to treat.

Methicillin resistance is a significant concern in healthcare settings, as it can lead to increased morbidity, mortality, and healthcare costs associated with treating infections caused by these bacteria. In recent years, there has been an increase in the prevalence of methicillin-resistant bacteria, highlighting the need for ongoing surveillance, infection control measures, and the development of new antibiotics to treat these infections.

Cilastatin is a medication that is primarily used as a stabilizer and renal protective agent for the antibiotic imipenem. Cilastatin works by inhibiting the deactivation of imipenem by renal dehydropeptidase-I, which helps maintain its therapeutic effectiveness in the body.

Imipenem/cilastatin is a combination medication used to treat various bacterial infections, including pneumonia, sepsis, and skin and urinary tract infections. Cilastatin does not have any antibacterial activity on its own.

It's important to note that the use of cilastatin should be under medical supervision, as with any medication. Always consult a healthcare professional for accurate information regarding medications and their uses.

'Campylobacter jejuni' is a gram-negative, spiral-shaped bacterium that is a common cause of foodborne illness worldwide. It is often found in the intestines of warm-blooded animals, including birds and mammals, and can be transmitted to humans through contaminated food or water.

The bacteria are capable of causing an infection known as campylobacteriosis, which is characterized by symptoms such as diarrhea, abdominal cramps, fever, and vomiting. In severe cases, the infection can spread to the bloodstream and cause serious complications, particularly in individuals with weakened immune systems.

'Campylobacter jejuni' is one of the most common causes of foodborne illness in the United States, with an estimated 1.3 million cases occurring each year. It is often found in undercooked poultry and raw or unpasteurized milk products, as well as in contaminated water supplies. Proper cooking and pasteurization can help reduce the risk of infection, as can good hygiene practices such as washing hands thoroughly after handling raw meat and vegetables.

"Mycobacterium fortuitum" is a rapidly growing mycobacterium (RGM) species that is commonly found in the environment, particularly in soil and water. It is a gram-positive, aerobic, non-tuberculous mycobacteria (NTM) that can cause a variety of infections in humans, including skin and soft tissue infections, lung infections, and disseminated disease.

M. fortuitum is known for its ability to form colonies on solid media within one week, which distinguishes it from other slow-growing mycobacteria such as Mycobacterium tuberculosis. It is also resistant to many common antibiotics, making treatment challenging. Infections caused by M. fortuitum are often associated with exposure to contaminated medical devices or procedures, such as contaminated tattoos, wound care, or invasive medical procedures.

It's important to note that while M. fortuitum can cause infections, it is not considered a highly virulent pathogen and most people who are exposed to it do not develop symptoms. However, individuals with weakened immune systems, such as those with HIV/AIDS or receiving immunosuppressive therapy, may be at higher risk for severe disease.

Metronidazole is an antibiotic and antiprotozoal medication. It is primarily used to treat infections caused by anaerobic bacteria and certain parasites. Metronidazole works by interfering with the DNA of these organisms, which inhibits their ability to grow and multiply.

It is available in various forms, including tablets, capsules, creams, and gels, and is often used to treat conditions such as bacterial vaginosis, pelvic inflammatory disease, amebiasis, giardiasis, and pseudomembranous colitis.

Like all antibiotics, metronidazole should be taken only under the direction of a healthcare provider, as misuse can lead to antibiotic resistance and other complications.

... ciprofloxacin is not recommended as a first-line treatment for acute sinusitis. Ciprofloxacin is approved for the treatment of ... Oral and intravenous ciprofloxacin are approved by the FDA for use in children for only two indications due to the risk of ... Ciprofloxacin was stopped because of an adverse event in 1% of people treated with the medication by mouth. The most frequently ... Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses ...
Marketed as Cipro and generic ciprofloxacin), ciprofloxacin extended-release (Marketed as Cipro XR and Proquin XR), ... One example is ciprofloxacin, one of the most widely used antibiotics worldwide. Fluoroquinolones are often used for ... Bergan T, Dalhoff A, Thorsteinsson SB (1985). "A review of the pharmacokinetics and tissue penetration of ciprofloxacin": 23-36 ... danofloxacin - 2nd gen, related to ciprofloxacin difloxacin - 2nd/3rd gen, related to temafloxacin enrofloxacin - 2nd gen, ...
An antibiotic, ciprofloxacin, has also been seen to be a cause, known as ciprofloxacin-related hyperacusis. Benzodiazepine ... ISBN 978-1-118-10605-1. "Ciprofloxacin Related Hyperacusis". FDA Reports. 2017. Beeley L (June 1991). "Benzodiazepines and ...
Reeves RR (1992). "Ciprofloxacin-induced psychosis". Ann Pharmacother. 26 (7-8): 930-1. doi:10.1177/106002809202600716. PMID ... Azar S, Ramjiani A, Van Gerpen JA (April 2005). "Ciprofloxacin-induced chorea". Mov. Disord. 20 (4): 513-4, author reply 514. ... Mulhall JP, Bergmann LS (July 1995). "Ciprofloxacin-induced acute psychosis". Urology. 46 (1): 102-3. doi:10.1016/S0090-4295(99 ...
Redirects to ciprofloxacin. progabide (INN) Progestasert progesterone (INN) proglumetacin (INN) proglumide (INN) Proglycem ...
Ciprofloxacin reached the market just one year after norfloxacin and achieved sales of 1.5 billion Euros at its peak. Kyorin ... Ciprofloxacin is being licensed for the treatment of Complicated Urinary Tract Infections and Pyelonephritis due to Escherichia ... Harder S, Fuhr U, Staib AH, Wolff T (November 1989). "Ciprofloxacin-caffeine: a drug interaction established using in vivo and ... Additionally other fluoroquinolones, especially enoxacin, and to a lesser extent ciprofloxacin and pefloxacin, also inhibit the ...
Babar, Sultan M. (October 2013). "SIADH associated with ciprofloxacin". The Annals of Pharmacotherapy. 47 (10): 1359-1363. doi: ...
Babar SM (October 2013). "SIADH associated with ciprofloxacin". The Annals of Pharmacotherapy. 47 (10): 1359-63. doi:10.1177/ ...
Babar SM (October 2013). "SIADH associated with ciprofloxacin". The Annals of Pharmacotherapy. 47 (10): 1359-1363. doi:10.1177/ ... The overall frequency of fluoroquinolone-associated Achilles tendon rupture in patients treated with ciprofloxacin or ... and ciprofloxacin, which had a broader spectrum, was already on the market. By 1992, an intravenous solution was approved for ... ciprofloxacin and levofloxacin) only minimally prolong the QT interval. Clostridium difficile-associated diarrhea may occur in ...
It has also been associated with fluoroquinolones (including ciprofloxacin and moxifloxacin). Finally, it can occur without a ... ISBN 978-0-387-30348-2. Babar SM (October 2013). "SIADH associated with ciprofloxacin". The Annals of Pharmacotherapy. 47 (10 ...
Babar SM (October 2013). "SIADH associated with ciprofloxacin". The Annals of Pharmacotherapy. 47 (10): 1359-1363. doi:10.1177/ ...
for Ciprofloxacin O-Flox, abrev. for Ofloxacin FLOX, abrev. for chemotherapy protocol used in the USA (FOLFLOX in EU), ...
Babar, S. (October 2013). "SIADH Associated With Ciprofloxacin" (PDF). The Annals of Pharmacotherapy. 47 (10): 1359-63. doi: ...
van Furth, R.; van't Wout, J.W.; Zwartendijk, J.; Wertheimer, P.A. (January 1992). "Ciprofloxacin for treatment of malakoplakia ... Antibiotics such as trimethoprim-sulfamethoxazole or ciprofloxacin may be used. Leonor Michaelis and Carl Gutmann first ...
These include ciprofloxacin and levofloxacin. Fluorine also finds use in steroids: fludrocortisone is a blood pressure-raising ...
Ciprodex ear drops containing ciprofloxacin and dexamethasone Ciproxin HC ear drops containing ciprofloxacin and hydrocortisone ... "Ciprofloxacin Otic: MedlinePlus Drug Information". medlineplus.gov. Retrieved 2022-07-28. "How to Use Ear Drops" (PDF). Safe ... "Ciprofloxacin And Dexamethasone (Otic Route) Side Effects - Mayo Clinic". www.mayoclinic.org. Retrieved 2022-08-01. "Kenacomb ... apply 5 drops to the affected ear twice daily Ciprofloxacin with hydrocortisone; apply 3 drops to the affected ear twice daily ...
"FDA approves generic forms of ciprofloxacin". CIDRAP. Retrieved July 17, 2018. "MYLAN's MAXZIDE IS "APPROVABLE" AT FDA: LEDERLE ...
Dawson SJ, White LA (1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". J. Infect. 24 (3): 317-20. ...
Dawson SJ, White LA (1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". J. Infect. 24 (3): 317-20. ...
Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of ...
Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of ...
Dawson SJ, White LA (1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". J. Infect. 24 (3): 317-20. ...
Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of ...
Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of ...
Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of ...
Dawson SJ, White LA (1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". J. Infect. 24 (3): 317-20. ...
Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of ...
Dawson SJ, White LA (1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". J. Infect. 24 (3): 317-20. ...
"Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". J. Infect. 24 (3): 317-320. doi:10.1016/S0163-4453(05) ...
Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of ...
... ciprofloxacin is not recommended as a first-line treatment for acute sinusitis. Ciprofloxacin is approved for the treatment of ... Oral and intravenous ciprofloxacin are approved by the FDA for use in children for only two indications due to the risk of ... Ciprofloxacin was stopped because of an adverse event in 1% of people treated with the medication by mouth. The most frequently ... Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses ...
Ciprofloxacin: learn about side effects, dosage, special precautions, and more on MedlinePlus ... One type of ciprofloxacin cannot be substituted for another. Be sure that you receive only the type of ciprofloxacin that was ... Do not take ciprofloxacin with dairy products or calcium-fortified juices alone. However, you may take ciprofloxacin with a ... Take ciprofloxacin until you finish the prescription, even if you feel better. Do not stop taking ciprofloxacin without talking ...
... ciprofloxacin) are used with excellent results. The hazard of infection to industrial workers can be reduced by sterilization ... Other articles where ciprofloxacin is discussed: anthrax: Anthrax in humans and animals: , ... ciprofloxacin) are used with excellent results. The hazard of infection to industrial workers can be reduced by sterilization ...
Drug information provided by: Merative, Micromedex®. Your doctor will check your or your childs progress closely while you are receiving Otiprio®. Your doctor will also check your or your childs progress at regular visits while you are using Cetraxal®. This will allow your doctor to see if the medicine is working properly and to decide if you or your child should continue to use or receive it. ...
Advice for mothers using Ciprofloxacin while breastfeeding. Includes possible effects on breastfed infants and lactation. ... A woman took ciprofloxacin 500 mg daily orally for 10 days. At 10 hours and 40 minutes after the last dose, ciprofloxacin was ... Ciprofloxacin Levels and Effects while Breastfeeding. Summary of Use during Lactation. Amounts of ciprofloxacin in breastmilk ... Ciprofloxacin use in neonates: A systematic review of the literature. Pediatr Infect Dis J. 2011;30:e29-37. [PubMed: 21048525] ...
Detailed drug Information for Ciprofloxacin (Intravenous). Includes common brand names, drug descriptions, warnings, side ... Detailed Ciprofloxacin dosage information Precautions while using ciprofloxacin. It is very important that your doctor check ... Uses for ciprofloxacin. Ciprofloxacin injection is used to treat bacterial infections in many different parts of the body. It ... Generic name: ciprofloxacin [ sip-roe-FLOX-a-sin ]. Drug class: Quinolones and fluoroquinolones ...
Update prophylaxis practices per CDC guidance if multiple ciprofloxacin-resistant meningococcal cases are reported and make up ... Antibiotic prophylaxis with ciprofloxacin in areas with ciprofloxacin resistance can result in prophylaxis failure. This ... Recommendations for discontinuing use of ciprofloxacin. *Discontinue use of ciprofloxacin for prophylaxis of close contacts ... Cases caused by ciprofloxacin-resistant strains make up at least 20% of all reported invasive meningococcal disease cases. ...
Retrieved from "https://www.SNPedia.com/index.php?title=Ciprofloxacin&oldid=442435" ...
Ciprofloxacin ear solution or suspension is used to treat otitis externa. Otitis externa, also known as swimmers ear, is an ... Ciprofloxacin belongs to the class of medicines known as fluoroquinolone antibiotics. It works by killing the bacteria or ... studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of ciprofloxacin ... studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ciprofloxacin ...
Ciprofloxacin and dexamethasone otic (for the ear) is a combination medicine used to treat infections inside the ear (also ... called otitis media), and infections of the ear canal (also called otitis externa). . Ciprofloxacin and dexamethasone may also ... Ciprofloxacin is an antibiotic. Dexamethasone is a steroid. . ... What is ciprofloxacin and dexamethasone otic?. Ciprofloxacin is ... ciprofloxacin and dexamethasone otic ciprofloxacin and dexamethasone otic. Pronunciation: SIP roe FLOX a sin and DEX a METH a ...
... 2 minutes ago, Buy Ciprofloxacin 500 Mg Online from TRUST STORE! Buy Ciprofloxacin 500 Mg . Best ...
Injectable; Injection; Ciprofloxacin Hydrochloride 2 mg / ml*Tablets, Film-Coated; Oral; Ciprofloxacin Hydrochloride 250 mg* ...
... (Consumption), Revenue and share - published on openPR.com ... 1.2 Classification of Ciprofloxacin. 1.3 Application of Ciprofloxacin. 1.4 Ciprofloxacin Market by Regions. 1.5 Global Market ... Figure Picture of Ciprofloxacin. Table Classification of Ciprofloxacin. Figure Global Sales Market Share of Ciprofloxacin by ... As such, the Ciprofloxacin Market is bound to climb the digitized pedestal in the years to come. Ciprofloxacin is one of the ...
Toxicity. Ciprofloxacin has a very high chronic toxicity.. Risk. The use of ciprofloxacin (sales data Sweden 2019) has been ... Concrete proposal for ciprofloxacin. *Ciprofloxacin is recommended for febrile UTI in adults in the Wise list as alternative ... Persistence. Ciprofloxacin is potentially persistent.. Bioaccumulation. Ciprofloxacin has low potential for bioaccumulationn.. ... Ciprofloxacin is not readily biodegradable. Therefore, the phrase Ciprofloxacin is potentially persistent is chosen. ...
Ciprofloxacin is an antibiotic that belongs to the family of medications known as quinolones. It is used to treat infections ... 02245649 MYLAN-CIPROFLOXACIN 750MG TABLET. 02245648 MYLAN-CIPROFLOXACIN 500MG TABLET. 02245647 MYLAN-CIPROFLOXACIN 250MG TABLET ... Ciprofloxacin tablets may be taken with food or on an empty stomach. Drink plenty of fluids while taking ciprofloxacin. ... Although ciprofloxacin can be taken with meals that include milk, you should not take ciprofloxacin with dairy products alone ...
Ciprofloxacin is an antibiotic that belongs to the family of medications known as quinolones. It is used to treat infections ... Ciprofloxacin tablets may be taken with food or on an empty stomach. Drink plenty of fluids while taking ciprofloxacin. ... Although ciprofloxacin can be taken with meals that include milk, you should not take ciprofloxacin with dairy products alone ... you may need to take ciprofloxacin for 3 to 14 days. For bone infections it may be necessary to take ciprofloxacin for as long ...
Ciprofloxacin. The Anatomical Therapeutic Chemical (ATC) classification system from Drugs-about.com includes all drugs ... S02AA15 - Ciprofloxacin *Ciprofloxacin ATC Classification , Home Page , Sitemap , Terms & Conditions , Privacy Policy , Pharma ...
Learn more about Ciprofloxacin Otic (Cetraxal) at EverydayHealth.com. ... Find everything you need to know about Ciprofloxacin Otic (Cetraxal), including what it is used for, warnings, reviews, side ... Ciprofloxacin is an antibiotic in a group of drugs called fluoroquinolones (flor-o-KWIN-o-lones). Ciprofloxacin fights bacteria ... How to take Ciprofloxacin Otic (Cetraxal)?. Use Ciprofloxacin Otic (Cetraxal) exactly as directed on the label, or as ...
... is a fluoroquinolone (flor-o-KWIN-o-lone) antibiotic that fights bacteria in the body. Ciprofloxacin is used to ...
The objective of this study was to explore potential drug-drug/food interactions of ciprofloxacin and grapefruit juice, known ... Effect of Ciprofloxacin and Grapefruit juice on oral pharmacokinetics of Riluzole in Wistar rats , Objectives: ... Ciprofloxacin and norfloxacin also inhibited ethoxyresorufin-O-dealkylase (CYP1A). In contrast, ciprofloxacin and norfloxacin ... Effects of ciprofloxacin on the stereoselective disposition of mexiletine in man Punna Rao Ravi et al. CYP 1A2 inhibitors and ...
Ciprofloxacin (Cipro) vs other antibiotics - comparative analysis, results of head-to head comparative clinical trials. ... eMedExpert Home > Comparisons > Ciprofloxacin (Cipro). Ciprofloxacin (Cipro) versus Other Antibiotics. *Ciprofloxacin vs ... Ciprofloxacin vs Ofloxacin (Floxin). Both ofloxacin and ciprofloxacin are fluoroquinolones with similar properties. However, ... Results of double-blind comparison of ciprofloxacin with cefotaxime for skin and skin structure infections 20.. Ciprofloxacin. ...
Ciprofloxacin 750mg tablet This medication contains an antibiotic from the quinolone family. Typically, it is used to treat ...
Ngo H-S, Nguyen T-L, Tran N-T, Le H-C. Photocatalytic Removal of Ciprofloxacin in Water by Novel Sandwich-like CuFe2O4 on rGO/ ... Ngo H-S, Nguyen T-L, Tran N-T, Le H-C. Photocatalytic Removal of Ciprofloxacin in Water by Novel Sandwich-like CuFe2O4 on rGO/ ... Guo, H.-G.; Gao, N.-Y.; Chu, W.-H.; Li, L.; Zhang, Y.-J.; Gu, J.-S.; Gu, Y.-L. Photochemical Degradation of Ciprofloxacin in UV ... OH, h+, e− + ciprofloxacin → CO2 + H2O + simpler molecules. 3.6.3. Total Organic Carbon Measurement. Total organic carbon (TOC ...
Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Suspension (Par) ... 2-3 week study with 4 clinic visits to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile ... A Randomized, Double-Blind, Parallel, Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/ ... A Randomized, Double-Blind, Parallel, Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/ ...
Ciprofloxacin tablets can be taken with or without food.. *If you miss a dose of ciprofloxacin tablets and it is: * 6 hours or ... Do not use ciprofloxacin tablets for a condition for which it is not prescribed. Do not give ciprofloxacin tablets to other ... What are ciprofloxacin tablets? Ciprofloxacin tablets are a fluoroquinolone antibacterial medicine used in adults age 18 years ... Ciprofloxacin passes into your breast milk. *You should not breastfeed during treatment with ciprofloxacin tablets and for 2 ...
The first report of the qnrB19, qnrS1 and aac(6´)-Ib-cr genes in urinary isolates of ciprofloxacin-resistant Escherichia coli ... Prevalence in the United States of aac(6´)Ib-cr enconding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50: ... First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America. Antimicrob Agents ... A total of 101 ciprofloxacin-resistant E. coli isolates collected from the urine of women with clinical and laboratory ...
This study aimed to investigate the prevalence of ciprofloxacin-resistant K pneumoniae in burns patients and to understand the ... role of the AcrAB multidrug efflux system on minimal inhibitory concentration (MIC) of ciprofloxacin. For ... This study aimed to investigate the prevalence of ciprofloxacin-resistant K pneumoniae in burns patients and to understand the ... For this reason, 52 K pneumoniae samples were collected from burns patients and evaluated for the mechanism of ciprofloxacin ...
Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis ... Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis ... Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis ...
Combinations of concentrations of butyrophenones or control EPI (chlorpromazine) along with ciprofloxacin (CIP) were utilized ... such as ciprofloxacin. A mutation in the promoter region of norA increases the expression of the NorA efflux pump in S. aureus ... For all of our butyrophenone compounds we observed a reduction in the MIC of ciprofloxacin in S. aureus 1199B reversing its ... and its derivatives have potential for treating ciprofloxacin resistant S. aureus infections in combination therapy. ...
  • Viagra is indicated for the treatment of erectile dysfunction in men ciprofloxacin 500mg . (tenosiquetv.com)
  • La tua farmacia online ciprofloxacin 500mg . (tenosiquetv.com)
  • Farmacia online Espana: la venta (comprar) de medicamentos genéricos ciprofloxacin 500mg . (tenosiquetv.com)
  • Aceptamos VISA, Mastercard y Amex ciprofloxacin 500mg . (tenosiquetv.com)
  • Top Offering, Viagra Price Hike ciprofloxacin 500mg . (tenosiquetv.com)
  • Levitra is a prescription medication for the treatment of erectile dysfunction (ED) ciprofloxacin 500mg . (tenosiquetv.com)
  • Precio Viagra En Farmacias ciprofloxacin 500mg ciprofloxacin 500mg . (tenosiquetv.com)
  • Cialis is indicated for the treatment of erectile dysfunction.com : un choix immense, des prix mini ciprofloxacin 500mg . (tenosiquetv.com)
  • Welkom bij Apothecaris, uw online apotheek mét advies order ciprofloxacin 500mg . (psicoterapeutaonline.es)
  • order online pharmacy egypt online pharmacy uk free delivery httponlinepharmacymd cheap online pharmacy buy online pharmacy reviews Online Shopping Canada - Walmart order ciprofloxacin 500mg . (psicoterapeutaonline.es)
  • 14 Apr 2015 order ciprofloxacin 500mg . (psicoterapeutaonline.es)
  • Discounted generic medicines online at BM Pharmacy with Free Shipping order ciprofloxacin 500mg .S. how good is generic cialis . (psicoterapeutaonline.es)
  • Viagra order ciprofloxacin 500mg .ro - prima ta farmacie online NU EXISTA O VALOARE MINIMA A COMENZII. (psicoterapeutaonline.es)
  • O otherwise missed order ciprofloxacin 500mg . (psicoterapeutaonline.es)
  • Cheapest Rates, Buy Cialis By Phone order ciprofloxacin 500mg. (psicoterapeutaonline.es)
  • Cheapest Rates, Kamagra Jelly For Sale order ciprofloxacin 500mg. (psicoterapeutaonline.es)
  • Generics, Rx Refills order ciprofloxacin 500mg . (org.ua)
  • Free bonus pills, Worldwide Shipping, order ciprofloxacin 500mg . (org.ua)
  • Liquid severe reaction tadalafil tablets and sperm motility for puppy uti much ds without order ciprofloxacin 500mg . (org.ua)
  • Farmacia de Barcelona Online order ciprofloxacin 500mg . (org.ua)
  • Chemist Direct UK provides over 20000 health, pharmacy, beauty and prescription products online order ciprofloxacin 500mg . (org.ua)
  • SITES ( CM) Online Pharmacy Services RightSource has earned Verified Internet order ciprofloxacin 500mg . (org.ua)
  • 19 Place du 6 Juin 1944, 14500 Vire order ciprofloxacin 500mg . (org.ua)
  • online pharmacies that sell Vicodin, OxyContin, etc order ciprofloxacin 500mg . (org.ua)
  • Viagra Venta En Inglaterra order ciprofloxacin 500mg. (org.ua)
  • IMG] Nombre del producto: Amoxil Componente activo: Amoxicillin Se utiliza para: Amoxil Genérico se utiliza para tratar infecciones causadas order ciprofloxacin 500mg. (org.ua)
  • Sacip Sacip 500 (Ciprofloxacin (as HCL) USP 500mg tablet is usually prescribed for the treatment. (wanttono.com)
  • The best canadian pills cheaply buy ciprofloxacin 500mg online . (onlinehome.us)
  • FarmaCommento di Marta Spett buy ciprofloxacin 500mg online . (onlinehome.us)
  • Charles sheffield reprint vale buy ciprofloxacin 500mg online. (onlinehome.us)
  • Online Apotheke Cialis 20mg buy ciprofloxacin 500mg online . (onlinehome.us)
  • Livraison d' europe en DHL, paiement par visa et bitcoins, et paypal.S. buy dapoxetine online find Until we require out what we're responding to hold with the city and farmacie online the track, it's only senior to reduce medical buy ciprofloxacin 500mg online . (onlinehome.us)
  • Pharmacie en ligne française à Tournus (71) - Livraison gratuite 24/48h en France et Belgique buy ciprofloxacin 500mg online . (onlinehome.us)
  • Pharmacie Monge Levitra buy ciprofloxacin 500mg online . (onlinehome.us)
  • Effective medications with no adverse reactions at best prices ever buy ciprofloxacin 500mg online . (onlinehome.us)
  • webfarm farmacie online (Farmacia Omnia buy ciprofloxacin 500mg online . (onlinehome.us)
  • Im PharmaXia Online-Shop ab 20.S buy ciprofloxacin 500mg online . (onlinehome.us)
  • For example, the Infectious Diseases Society of America recommends the use of ciprofloxacin and other fluoroquinolones in urinary tract infections be reserved to cases of proven or expected resistance to narrower-spectrum drugs such as nitrofurantoin or trimethoprim/sulfamethoxazole. (wikipedia.org)
  • Fluoroquinolones such as ciprofloxacin have traditionally not been used in infants because of concern about adverse effects on the infants' developing joints. (drugs.com)
  • Fluoroquinolones, including ciprofloxacin, are associated with disabling and potentially irreversible serious adverse reactions that have occurred together, including tendinitis and tendon rupture, peripheral neuropathy, and CNS effects. (drugs.com)
  • Discontinue ciprofloxacin and avoid use of fluoroquinolones in patients with these serious adverse reactions. (drugs.com)
  • Fluoroquinolones, including ciprofloxacin, may exacerbate muscle weakness in persons with myasthenia gravis. (drugs.com)
  • Ciprofloxacin is an antibiotic in a group of drugs called fluoroquinolones (flor-o-KWIN-o-lones). (everydayhealth.com)
  • Both ofloxacin and ciprofloxacin are fluoroquinolones with similar properties. (emedexpert.com)
  • Damage to the nerves in arms, hands, legs, or feet can happen in people who take fluoroquinolones, including ciprofloxacin tablets. (nih.gov)
  • Fluoroquinolones like ciprofloxacin tablets may cause worsening of myasthenia gravis symptoms, including muscle weakness and breathing problems. (nih.gov)
  • Certainly, this is not the experience of everyone who takes Ciprofloxacin or the Fluoroquinolones, however, I liken it to playing Russian Roulette with a gun that has a thousand chambers and only one bullet. (fqresearch.org)
  • ABSTRACT Susceptibility of 88 clinical Streptococcus pneumoniae isolates, 116 Haemophilus influenzae isolates and 80 Moraxella catarrhalis isolates to 6 fluoroquinolones--ciprofloxacin, ofloxacin, levofloxacin, trovafloxacin, grepafloxacin and gemifloxacin--were determined. (who.int)
  • In Saudi Arabia, the only approved non-repeat isolates were collected by each fluoroquinolones are ciprofloxacin, ofloxa- centre. (who.int)
  • Ciprofloxacin is a fluoroquinolone antibiotic used to treat a number of bacterial infections. (wikipedia.org)
  • For example, ciprofloxacin in combination with metronidazole is one of several first-line antibiotic regimens recommended by the Infectious Diseases Society of America for the treatment of community-acquired abdominal infections in adults. (wikipedia.org)
  • Antibiotic prophylaxis with ciprofloxacin in areas with ciprofloxacin resistance can result in prophylaxis failure. (cdc.gov)
  • Ciprofloxacin is an antibiotic. (cigna.com)
  • Ciprofloxacin is a fluoroquinolone (flor-o-KWIN-o-lone) antibiotic that fights bacteria in the body. (darbydental.com)
  • Infecton consists of the synthetic broad-spectrum antibiotic ciprofloxacin linked to the radiochemical 99m Tc. (snmjournals.org)
  • There are several different treatments available for Lyme, with one of them being an antibiotic called Ciprofloxacin, also called Cipro. (fqresearch.org)
  • Four pills [of Levaquin, a Fluoroquinolone antibiotic related to Ciprofloxacin] later, I began experiencing the most heinous, violent, vicious, painful, ugly and destructive constellation of symptoms you can imagine. (fqresearch.org)
  • Ciprobay Ciprobay (Ciprofloxacin (as HCL)) tablet is a potent bactericidal antibiotic bacterial. (wanttono.com)
  • Ciprox Ciprox (Ciprofloxacin) Tablet is an antibiotic medicine used to treat different bacterial. (wanttono.com)
  • Ciproquine Ciproquine (Ciprofloxacin) Tablet is a broad-spectrum antibiotic medicine usually. (wanttono.com)
  • You should not use this medicine if you are allergic to ciprofloxacin (Cipro) or similar antibiotics, such as gemifloxacin, levofloxacin, moxifloxacin, norfloxacin, or ofloxacin. (everydayhealth.com)
  • Things are looking more than a little bleak for President Barack Obama's health care reform initiative: polls show Buy cheap Cipro(Ciprofloxacin) online , public support dropping, increasing numbers of people profess to be confused by the issue , the GOP stands emboldened in opposition as right wing talking points predominate in the media and "centrist" Democrats, true to form, cause endless mischief. (lastchancedemocracycafe.com)
  • One downside to Obama's desire to stay above the nitty-gritty of the debate -- leaving the details for Congress -- has been that it's left him without a clear vision to communicate to the American people, buy cheap Cipro(Ciprofloxacin) online . (lastchancedemocracycafe.com)
  • Not exactly awe-inspiring rhetoric from a guy known for his awe-inspiring rhetoric, order Cipro(Ciprofloxacin) online legally . (lastchancedemocracycafe.com)
  • Buy cheap Cipro(Ciprofloxacin) online , The question that needs be asked is: So then what exactly is Republicancare. (lastchancedemocracycafe.com)
  • Because the answer, Kjøpe Cipro(Ciprofloxacin) , of course, is that they are proposing nothing -- nothing that is other than more of the same. (lastchancedemocracycafe.com)
  • Obama's proposals may be far from perfect: God knows, many liberals, Cipro(Ciprofloxacin) generic , myself included, aren't overly enchanted with them. (lastchancedemocracycafe.com)
  • Cipro(Ciprofloxacin) online cheap , But right now (and for the foreseeable future) they're the only game in town. (lastchancedemocracycafe.com)
  • If the Republicans in Congress have made anything clear, it is that the only thing they care about is scoring political points by trying to kill anything Obama and the Democrats put up in this area, buy cheap Cipro(Ciprofloxacin) online . (lastchancedemocracycafe.com)
  • That's the message Democrats need to be taking to the American people: It's your choice, order Cipro(Ciprofloxacin) pills , folks, Obamacare or Republicancare - meaningful, Maryland MD Md. , if imperfect, reform, or more of the same. (lastchancedemocracycafe.com)
  • If you're happy with the status quo, köpa Cipro(Ciprofloxacin) online , great, because that's exactly what the GOP will give you. (lastchancedemocracycafe.com)
  • In this study, we investigated the presence of plasmid-mediated quinolone resistance (PMQR) genes among 101 ciprofloxacin-resistant urinary Escherichia coli isolates and searched for mutations in the quinolone-resistance-determining regions (QRDRs) of the DNA gyrase and topoisomerase IV genes in PMQR-carrying isolates. (scielo.br)
  • Therefore, in this study, we investigated the presence of the qnrA , qnrB , qnrS and aac(6-)-Ib-cr genes in a sample of ciprofloxacin-resistant E. coli isolates from women with CA-UTIs. (scielo.br)
  • The results demonstrated that 40 isolates of K pneumoniae were ciprofloxacin-resistant and 35 showed the mutation on gyrA locus. (uwi.edu)
  • For each isolates Minimum Inhibitory Concentrations (MIC) for Metronidazole (MTZ), Amoxicillin (AMX), Tetracycline (TC) and Ciprofloxacin (CIP) were determined by Epsilometer test. (scialert.net)
  • All San Francisco isolates, and 89% of isolates overall, were resistant to ciprofloxacin. (cdc.gov)
  • The recommended adult dose of ciprofloxacin tablets ranges from 250 mg to 750 mg twice daily. (medbroadcast.com)
  • Ciprofloxacin tablets may be taken with food or on an empty stomach. (medbroadcast.com)
  • These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. (nih.gov)
  • See full prescribing information for CIPROFLOXACIN TABLETS. (nih.gov)
  • Read this Medication Guide before you start taking ciprofloxacin tablets and each time you get a refill. (nih.gov)
  • Ciprofloxacin tablets, a fluoroquinolone antibacterial medicine, can cause serious side effects. (nih.gov)
  • If you get any of the following serious side effects while you take ciprofloxacin tablets, you should stop taking ciprofloxacin tablets immediately and get medical help right away. (nih.gov)
  • Tendon problems can happen in people of all ages who take ciprofloxacin tablets. (nih.gov)
  • Tendon problems can happen in people who do not have the above risk factors when they take ciprofloxacin tablets. (nih.gov)
  • Stop taking ciprofloxacin tablets immediately and get medical help right away at the first sign of tendon pain, swelling or inflammation. (nih.gov)
  • Tendon rupture can happen while you are taking or after you have finished taking ciprofloxacin tablets. (nih.gov)
  • Tendon ruptures can happen within hours or days of taking ciprofloxacin tablets and have happened up to several months after people have finished taking their fluoroquinolone. (nih.gov)
  • Ciprofloxacin tablets may need to be stopped to prevent permanent nerve damage. (nih.gov)
  • Mental health problems and seizures have been reported in people who take fluoroquinolone antibacterial medicines, including ciprofloxacin tablets. (nih.gov)
  • Tell your healthcare provider if you have a history of seizures before you start taking ciprofloxacin tablets. (nih.gov)
  • CNS side effects may happen as soon as after taking the first dose of ciprofloxacin tablets. (nih.gov)
  • What are ciprofloxacin tablets? (nih.gov)
  • Ciprofloxacin tablets are a fluoroquinolone antibacterial medicine used in adults age 18 years and older to treat certain infections caused by certain germs called bacteria. (nih.gov)
  • Jawaflox Jawaflox (Ciprofloxacin as HCL USP) tablets are manufactured by Jawa Pharmaceuticals. (wanttono.com)
  • Ciprofloxacin belongs to the class of drugs known as quinolone antibiotics. (drugs.com)
  • In present study we confronted with markedly high rate of resistance to metronidazole and ciprofloxacin, furthermore other antibiotics displayed significant resistance rate and there was some level of overlap between resistances to these drugs. (scialert.net)
  • In Staphylococcus aureus , the membrane protein NorA has been found to mediate the efflux of hydrophilic fluoroquinolone antibiotics, such as ciprofloxacin. (confex.com)
  • While Levofloxacin and Ciprofloxacin for Lyme are effective, and thousands have used them for that reason, there is a possibility of having the harsh downsides of lifelong pain, disability, and even Death from the Fluoroquinolone Class of Antibiotics . (fqresearch.org)
  • Crescip DS Crescip DS (Ciprofloxacin HCl (USP)) tablet belongs to a class of quinolone antibiotics. (wanttono.com)
  • Taking ciprofloxacin may worsen muscle weakness in people with myasthenia gravis (a disorder of the nervous system that causes muscle weakness) and cause severe difficulty breathing or death. (medlineplus.gov)
  • If you have myasthenia gravis and your doctor tells you that you should take ciprofloxacin, call your doctor immediately if you experience muscle weakness or difficulty breathing during your treatment. (medlineplus.gov)
  • Ten lactating women (time postpartum not stated) were given ciprofloxacin 750 mg orally every 12 hours for 3 doses. (drugs.com)
  • Your doctor may tell you not to take ciprofloxacin. (medlineplus.gov)
  • Depending on the type of infection being treated, you may need to take ciprofloxacin for 3 to 14 days. (medbroadcast.com)
  • For bone infections it may be necessary to take ciprofloxacin for as long as 3 months. (medbroadcast.com)
  • Although ciprofloxacin can be taken with meals that include milk, you should not take ciprofloxacin with dairy products alone or with calcium-fortified products. (medbroadcast.com)
  • Can I take Ciprofloxacin Otic (Cetraxal) if I'm pregnant or breastfeeding? (everydayhealth.com)
  • Drug interactions are reported among 161 people who take Ciprofloxacin and Colchicine. (ehealthme.com)
  • The phase IV clinical study analyzes what interactions people who take Ciprofloxacin and Colchicine have. (ehealthme.com)
  • 161 people who take Ciprofloxacin and Colchicine together, and have interactions are studied. (ehealthme.com)
  • Do you take Ciprofloxacin and Colchicine? (ehealthme.com)
  • In all 3 cases, ciprofloxacin was prescribed for urinary tract infection . (bvsalud.org)
  • Ciprofloxacin injection is used to treat bacterial infections in many different parts of the body. (drugs.com)
  • Ciprofloxacin is used to treat different types of bacterial infections. (darbydental.com)
  • Nicil Nicil (Ciprofloxacin) Tablet is usually used for the treatment of bacterial infections like. (wanttono.com)
  • Ciprofloxacin is a fluoroquinolone that is used for bacterial infections involving different systems. (bvsalud.org)
  • What is the most important information I should know about ciprofloxacin and dexamethasone otic? (cigna.com)
  • Ciprofloxacin and dexamethasone otic (for the ear) is a combination medicine used to treat infections inside the ear (also called otitis media), and infections of the ear canal (also called otitis externa). (cigna.com)
  • Ciprofloxacin and dexamethasone may also be used for purposes not listed in this medication guide. (cigna.com)
  • What should I discuss with my healthcare provider before using ciprofloxacin and dexamethasone otic? (cigna.com)
  • Ciprofloxacin and dexamethasone should not be used on a child younger than 6 months old. (cigna.com)
  • How should I use ciprofloxacin and dexamethasone otic? (cigna.com)
  • What should I avoid while using ciprofloxacin and dexamethasone otic? (cigna.com)
  • 2-3 week study with 4 clinic visits to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Suspension (Par) Compared to CIPRODEX (ciprofloxacin 0.3%/dexamethasone 0.1%) Sterile Otic Suspension (Alcon) ear drops for male and female children ages 6 months - 12 years. (centerwatch.com)
  • Each white, oval, film-coated tablet, imprinted with 'R' on one side and '127' on the other, contains ciprofloxacin (as the hydrochloride) 500 mg. (medbroadcast.com)
  • High-level ciprofloxacin resistance in Neisseria gonorrhoeae: first report from Israel. (cdc.gov)
  • Azithromycin may also be used in areas with ciprofloxacin-resistant strains. (cdc.gov)
  • Prescribe rifampin, ceftriaxone, or azithromycin instead of ciprofloxacin as prophylaxis when the threshold criteria have been reached. (cdc.gov)
  • CDC continues to receive new reports of infections with Shigella strains that are not susceptible to ciprofloxacin and/or azithromycin, the antimicrobial agents most commonly used to treat shigellosis. (cdc.gov)
  • 2 The catchment area should be a single continuous area that contains all counties reporting ciprofloxacin-resistant cases. (cdc.gov)
  • With a highlight on these changes, this research study presents an in-depth analysis of the worldwide Ciprofloxacin market during the period from 2018 to 2023. (openpr.com)
  • SITES ( CM) Online Pharmacy Services RightSource has earned Verified Internet is ciprofloxacin used for urinary tract infections . (propertiesinculvercity.com)
  • Better Internet Pharmacy.es, farmacia en línea, ofrece varios productos de higiene y el cuidado de su tienda en línea. (propertiesinculvercity.com)
  • CVS pharmacy - Farmacia en línea - Compre productos de belleza y bienestar. (tenosiquetv.com)
  • In the United States, ciprofloxacin is pregnancy category C. This category includes drugs for which no adequate and well-controlled studies in human pregnancy exist, and for which animal studies have suggested the potential for harm to the fetus, but potential benefits may warrant use of the drug in pregnant women despite potential risks. (wikipedia.org)
  • Patients in the study may take other drugs besides Ciprofloxacin and Colchicine. (ehealthme.com)
  • Cialis works faster than other ED drugs and is ciprofloxacin used for urinary tract infections . (propertiesinculvercity.com)
  • Cytotec is used for reducing the risk of stomach ulcers in certain patients who take nonsteroidal anti-inflammatory drugs (NSAIDs) ciprofloxacin 500 mg without pres . (psicoterapeutaonline.es)
  • If you experience any of the following symptoms of tendon rupture, stop taking ciprofloxacin and get emergency medical treatment: hearing or feeling a snap or pop in a tendon area, bruising after an injury to a tendon area, or inability to move or to bear weight on an affected area. (medlineplus.gov)
  • Taking ciprofloxacin may cause changes in sensation and nerve damage that may not go away even after you stop taking ciprofloxacin. (medlineplus.gov)
  • This can occur after the first dose of ciprofloxacin. (medlineplus.gov)
  • One mother who was recovering from acute renal failure was given a single dose of ciprofloxacin 500 mg orally with a prenatal vitamin and ferrous sulfate which would be expected to decrease ciprofloxacin bioavailability. (drugs.com)
  • A mutation in the promoter region of norA increases the expression of the NorA efflux pump in S. aureus strain 1199B resulting in resistance to ciprofloxacin. (confex.com)
  • Pseudomonas aeruginosa was sensitive to gentamicin (87.5) and ceftazidime (85.7) but showed resistance to ciprofloxacin (57.2). (bvsalud.org)
  • Objectives: The objective of this study was to explore potential drug-drug/food interactions of ciprofloxacin and grapefruit juice, known hepatic cytochrome P450 (CYP) 1A2 inhibitors, on single-dose oral pharmacokinetics of riluzole, a substrate of CYP 1A2 enzymes. (researchgate.net)
  • Gardner DK, Gabbe SG, Harter C. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant. (drugs.com)
  • Combinations of concentrations of butyrophenones or control EPI (chlorpromazine) along with ciprofloxacin (CIP) were utilized in checkerboard assays to determine their minimum inhibitory concentration (MIC) and fractional inhibitory concentration (FIC). (confex.com)
  • 99m Tc-labeled ciprofloxacin (infecton) has been developed for detecting infectious foci, which localize in high concentrations in living bacteria. (snmjournals.org)
  • Gagnez du temps : Sélectionnez en ligne, retirez en pharmacie.com : un choix immense, des prix mini. (totalcontrol.hu)
  • La parapharmacie en ligne de produits Pharmacie Lafayette Gengembre est géré par la .Bang diazepam farmacie online on Yamuna Expressway. (propertiesinculvercity.com)
  • Pharmacie de Steinfort au Luxembourg, vente en ligne de produits de pharmacie et parapharmacie des plus grandes marque. (psicoterapeutaonline.es)
  • acheter dexametasona 15 g pharmacie en ligne ordonnance. (psicoterapeutaonline.es)
  • Pharmacie En Ligne Viagra. (psicoterapeutaonline.es)
  • Pharmacie en ligne NEWPHARMA ✓ 30. (psicoterapeutaonline.es)
  • Synthroid pharmacie en france chiffre d affaires. (org.ua)
  • Gagnez du temps : Sélectionnez en ligne, retirez en pharmacie. (onlinehome.us)
  • SOSbobo parapharmacie en ligne contrôlée par un docteur en pharmacie afin de vous assurer la qualité des produits, leur origine et leur traçabilité. (onlinehome.us)
  • Pharmacie en ligne française à Tournus (71) - Livraison gratuite 24/48h en France et Belgique. (psicoterapeutaonline.es)
  • For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent. (wikipedia.org)
  • Ciprofloxacin occupies an important role in treatment guidelines issued by major medical societies for the treatment of serious infections, especially those likely to be caused by Gram-negative bacteria, including Pseudomonas aeruginosa. (wikipedia.org)
  • Although approved by regulatory authorities for the treatment of respiratory infections, ciprofloxacin is not recommended for respiratory infections by most treatment guidelines due in part to its modest activity against the common respiratory pathogen Streptococcus pneumoniae. (wikipedia.org)
  • and infections of the skin, bone, joint, abdomen (stomach area), and prostate (male reproductive gland), Ciprofloxacin is also used to treat or prevent plague (a serious infection that may be spread on purpose as part of a bioterror attack) and inhalation anthrax (a serious infection that may be spread by anthrax germs in the air on purpose as part of a bioterror attack). (medlineplus.gov)
  • Ciprofloxacin injection may be used in children to prevent anthrax infection after possible exposure, and to treat serious kidney infections. (drugs.com)
  • The extended release form of ciprofloxacin is used to treat bladder and kidney infections. (medbroadcast.com)
  • Ciprofloxacin otic (for use in the ears) is used to treat ear infections that affect the outer ear canal (also called otitis externa). (everydayhealth.com)
  • All together these results show that butyrophenones are inhibitors of the NorA efflux pump , and its derivatives have potential for treating ciprofloxacin resistant S. aureus infections in combination therapy. (confex.com)
  • Check our offer with FREE Silagra US Delivery is ciprofloxacin used for urinary tract infections . (propertiesinculvercity.com)
  • Fast shipping, Safe checkout, Credit cards accepted, is ciprofloxacin used for urinary tract infections . (propertiesinculvercity.com)
  • Servicios is ciprofloxacin used for urinary tract infections .V. Second Is Since I Take Avlocardyl Got Some Chest Pain is ciprofloxacin used for urinary tract infections. (propertiesinculvercity.com)
  • Prudente y seguro is ciprofloxacin used for urinary tract infections . (propertiesinculvercity.com)
  • En nuestra farmacia online encuentra medicinas is ciprofloxacin used for urinary tract infections . (propertiesinculvercity.com)
  • Although ciprofloxacin is widely prescribed for different infections , only 13 cases were reported to develop myoclonus secondary to ciprofloxacin . (bvsalud.org)
  • Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with ciprofloxacin. (medlineplus.gov)
  • Similarly, ciprofloxacin is not recommended as a first-line treatment for acute sinusitis. (wikipedia.org)
  • Reserve use of ciprofloxacin for patients with no alternative treatment options for an acute exacerbation of chronic bronchitis or acute sinusitis. (drugs.com)
  • Therefore, it could be concluded that the high rate of mutation on the gyrA locus in combination with quinolone resistance was responsible for ciprofloxacin resistance and by inhibition of AcrA, the resistance rate showed a significant decrease in K pneumoniae isolated from burns patients. (uwi.edu)
  • Farmacia de Internet - Drogas baratas en linea. (totalcontrol.hu)
  • Farmacia en linea España - Venta online de medicamentos sin receta - Cómo comprar medicamentos 'online' de forma segura? (totalcontrol.hu)
  • Cialis works faster than other ED . Tadalafil En Farmacia. (totalcontrol.hu)
  • Protéjase de los medicamentos no seguros aprendiendo a distinguir si una farmacia en línea es legal y segura. (tenosiquetv.com)
  • Viagra En Farmacia. (org.ua)
  • Farmacia en línea, Precios baratos. (onlinehome.us)
  • Farmacia en línea de Costa Rica. (onlinehome.us)
  • What is Ciprofloxacin Otic (Cetraxal) used for? (everydayhealth.com)
  • Use Ciprofloxacin Otic (Cetraxal) exactly as directed on the label, or as prescribed by your doctor. (everydayhealth.com)
  • Measurements have shown that ciprofloxacin is present in the Swedish wastewater treatment plants at levels posing risk of selection of resistant bacteria. (janusinfo.se)
  • This agent combines the advantages of a 99m Tc label and the broad-spectrum bacteria-localizing capability of ciprofloxacin. (snmjournals.org)
  • Methods: Pharmacokinetic parameters of riluzole were determined in Wistar rats after single-dose co-administration with ciprofloxacin and grapefruit juice. (researchgate.net)
  • CP ZAF CP ZAF (Ciprofloxacin USP) tablet is a Quinolone-Broad Spectrum Antibacterial medicine used. (wanttono.com)
  • Pivmecillinam achieved success in patients with A. urinae cystitis and ciprofloxacin in patients with pyelonephritis. (lu.se)
  • Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of ciprofloxacin injection in children. (drugs.com)
  • However, elderly patients are more likely to have age-related heart or kidney problems, or develop severe tendon problems (including tendon rupture), which may require caution in patients receiving ciprofloxacin injection. (drugs.com)
  • Taking ciprofloxacin increases the risk that you will develop tendinitis (swelling of a fibrous tissue that connects a bone to a muscle) or have a tendon rupture (tearing of a fibrous tissue that connects a bone to a muscle) during your treatment or for up to several months afterward. (medlineplus.gov)
  • Therefore the watch-list monitoring obligation for the three substances or groups of substances that had been on the list since 2018, namely metaflumizone, amoxicillin and ciprofloxacin, ceased in 2022. (janusinfo.se)
  • Online Apotheke Viagra Ohne Rezept ciprofloxacin 500 mg without pres . (totalcontrol.hu)
  • Viagra ciprofloxacin 500 mg without pres. (totalcontrol.hu)
  • Viagra en ligne suisse vente 25mg prix pfizer 100mg achat pilule générique canadien prescription de generique sans ordonnance. (totalcontrol.hu)
  • Viagra is indicated for the treatment of erectile dysfunction in men ciprofloxacin 500 mg without pres. (totalcontrol.hu)
  • Conclusions: Co-administration of ciprofloxacin with riluzole increases the systemic levels of riluzole and thereby the oral pharmacokinetic properties of riluzole while co-administration of grapefruit juice with riluzole has no significant effect. (researchgate.net)
  • Order dapoxetine online purchase india dosage gef?hrlich pil ciprofloxacin 500 mg without pres . (totalcontrol.hu)
  • Ciprofloxacin was used as part of multi-drug regimens to treat three pregnant women with multidrug-resistant tuberculosis throughout pregnancy and postpartum. (drugs.com)
  • However, the number of cases caused by ciprofloxacin-resistant strains has been increasing. (cdc.gov)
  • Cases caused by ciprofloxacin-resistant strains make up at least 20% of all reported invasive meningococcal disease cases. (cdc.gov)
  • Maintain updated prophylaxis guidance until a full 24 months have passed without any invasive meningococcal disease cases caused by ciprofloxacin-resistant strains having been reported in the catchment area. (cdc.gov)
  • This study aimed to investigate the prevalence of ciprofloxacin-resistant K pneumoniae in burns patients and to understand the role of the AcrAB multidrug efflux system on minimal inhibitory concentration (MIC) of ciprofloxacin. (uwi.edu)
  • For all of our butyrophenone compounds we observed a reduction in the MIC of ciprofloxacin in S. aureus 1199B reversing its susceptibility from resistant to susceptible. (confex.com)
  • only Klebsiella species were significantly resistant (p0.05) to ciprofloxacin. (bvsalud.org)
  • Ciprofloxacin was patented in 1980 and introduced in 1987. (wikipedia.org)
  • Between 2001 and 2002, prevalence of ciprofloxacin resistance increased two to three-fold, irrespective of recent sexual contact overseas, sex, or residence within or outside of London. (nih.gov)
  • This guidance is intended to help health departments decide when, where, and for how long they should discontinue use of ciprofloxacin for prophylaxis of close contacts 1 of patients with invasive meningococcal disease in their jurisdictions. (cdc.gov)
  • haloperidol, droperidol and spiperone, as NorA efflux pump inhibitors that reverse ciprofloxacin resistance in S. aureus 1199B. (confex.com)
  • Farmacie Online Cialis ciprofloxacin 500 mg without pres ciprofloxacin 500 mg without pres . (psicoterapeutaonline.es)
  • For this reason, 52 K pneumoniae samples were collected from burns patients and evaluated for the mechanism of ciprofloxacin resistance. (uwi.edu)
  • Checkerboard assays resulted in average FIC for droperidol, haloperidol, and spiperone of 0.195, 0.2 and 0.172 respectively, demonstrating a synergistic mechanism with ciprofloxacin for all three compounds (FIC ≤ 0.5). (confex.com)
  • The mechanism of ciprofloxacin -induced myoclonus is probably associated with γ- aminobutyric acid and glutamate pathways. (bvsalud.org)